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Relevance
Functioning disease surveillance networks contribute to reduce the socio-economic impact caused by epidemics. Once national governments and
partners involved adhere to policies and strategies to contain epidemics and
disease threats, strengthening of surveillance-response networks becomes an
option and effectively contributes to improving health systems. The Disease
Surveillance Networks (DSN) Initiative in Africa builds on existing national,
regional and global initiatives, with the inclusion of wildlife health as a con-
textual adaptation.
Niche
The Rockefeller Foundation is unique among funding institutions in its sup-
port for development of DSN globally. Supporting the institutionalization of
disease surveillance networks is seen as a potential core area for the Founda-
tion because of its long-term experience in funding DSN. The investment in
disease surveillance is of benefit not only for Africa, but also globally. The
Foundation is free to invest in areas it recognizes as important because
experts are empowered to carry out the practical work without operational
interference. Grantees appreciate having a “working partner” relationship
with an “honest broker,” rather than an “expert/trainee” relationship. The
Foundation clearly has a niche and comparative advantage in public health
and health systems research with an emphasis on societal and ecological
determinants of health, including One Health (i.e., connections between 
animal health, human health and environmental health). Through its global
engagement, the Foundation harbors the potential to enhance its output
through networking between continents.
Effectiveness
Capacity building in disease surveillance and in One Health has been
increased at the community, district, and national levels, but less progress has
been made institutionally. Grantees feel that their techniques have been well
accepted. Inter-sector and cross-boundary collaborations are innovative but
still in the initial phases and requiring more formal approaches to develop.
These collaborations should increase as open questions on ownership, man-
agement and sharing of national data as well as the roles of local experts are
clarified. New information and communication technologies (ICT) have
improved communication within the health management information system
(HMIS). Some computer servers were relocated to African countries resulting
in increased local ownership. Policy influence is taking place but seems lim-
ited to individuals and would need a conceptual framework. Users of DSN
Executive Summary
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are communities, livestock holders and traders, as well as professional organi-
zations, private veterinarians and physicians, and all levels of governmental
health systems and international agencies. Uses of DSN are improved capac-
ity in disease surveillance, increased collaboration between sectors, accelerated
detection of disease, enhanced communication and faster response. Research
capacity has been built at postdoctoral, Ph.D. and master’s degree of science
(MSc) levels. 
One Health
The Rockefeller Foundation can be considered the world-leading grantmaker
for One Health. Perhaps this results from an open culture of breaking silos
between disciplines towards a united approach of professionals working
together. Grantees agree that there has been an increase in One Health capac-
ity building in academia and governments, and an increase in transdiscipli-
nary and One Health leadership resulting from grant activities. However,
actual change towards closer integration at the government level happens
more often under the pressure of outbreaks. One of the challenges in advo-
cating the One Health concept in communities is the process of translation
into local languages. The added value of the One Health approach is a joint
use of synergies in infrastructure, capacity building, resources (human and
financial), and interventions between public health and animal health sectors.
At this stage most of these actions are not yet formalized. One Health as a
concept is not specified in written documentation. No reference to published
concept papers could be found. Interviewees gave rather operational defini-
tions and there was not yet a clear strategy to delineate and guide activities.
Sustainability
There is increased awareness that sustainability of DSN depends on owner-
ship of national capacity and strengthened national institutions. There is
good interaction with governmental agencies, and policy dialogue has
occurred, but this is a slow process in East Africa. The nexus between proj-
ects and governments is still weak.
Impact
Improved effectiveness of DSN in addressing specific disease threats can be
summarized mainly through increased awareness and better communication.
Cross-border collaboration has increased and the surveillance function has
been strengthened, but this is still at an early stage. It is difficult to assess
measurable impact on population health for this reason.
Final 
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Efficiency
Grantees agreed that feedback to communities, authorities and stakeholders
is very important. There is growing awareness at governmental and academic
levels that communities should be more actively involved in the planning and
implementation of projects. Monitoring and evaluation practices within
grants were informal and not well documented. This seemed not to be a
focus of the initiative. Little scientific documentation and publication was
observed to date. Not all projects are highly scientific, but most could pub-
lish their experiences. Resources were considered adequate for project goals
and capacity building. Foundation management support was perceived as
responsive and not bureaucratic. Grantees valued the opportunities the 
Foundation provided for them to interact with each other.
Conclusion
The Rockefeller Foundation is a leading institution in fostering DSN and
One Health in Africa and worldwide. The DSN Initiative in Africa has
improved capacity in disease surveillance, facilitated a change of attitude
between sectors, accelerated the detection of human and animal disease, 
and enhanced communication and response. Research capacity has been 
built at postdoctoral, Ph.D. and MSc levels. Capacity building in disease 
surveillance and One Health has been increased at all levels.
Disease surveillance networks require future support and should not be
phased out at the current stage. National surveillance capacity and political
support appear weaker than in the Mekong region and require prolonged
engagement towards sustainability. Communication between sectors has
increased, but is limited to individuals. Cross-border collaboration is at an
early stage and not sufficiently formalized.
There is little scientific publication in the international literature and the 
visibility of the Foundation is rather low with regard to its investment. 
The Foundation follows a flexible grant selection strategy, allowing for grant
applicants and authorities to contribute to shaping the initiative. 
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Recommendations
The Rockefeller Foundation is probably the most important donor in One
Health worldwide. Despite improved surveillance in the Africa DSN,
response capacity remains weak. Africa is endemic for emerging diseases, but
the whole world is also at risk through globalization. We recommend pro-
longing the current DSN Initiative in Africa to achieve sustainable DSN. 
Current grants are small and insufficient to sustain regional or Africa-wide
initiatives. We recommend that the Foundation examine options for contin-
ued support of the most successful projects. 
The Foundation should encourage grantees to broaden dissemination of best
practices, which will stimulate policy dialogue. We recommend a clear expec-
tation of scientific documentation through publication and increased refer-
ence to the Foundation to enhance its visibility. 
Future Core Areas of the Rockefeller Foundation and Leadership
The Rockefeller Foundation has a highly credible One Health engagement
and should conceptually strengthen ecosystems approaches to health. The
Foundation could take leadership in integrated development research through
stronger interconnections in its overall program. For example, well-established
competence and experience in the Foundation should address the rapidly
growing food security crisis through integrated agriculture-health, One Health
and ecosystem-health approaches. Other United States institutions are not
viewed as having such resources. The closest conceptual “competitor” is the
International Development Research Centre (IDRC) in Ottawa.
The Foundation should support national governments in developing adapted
legislation for the institutionalization and academic curriculum revision to
build and sustain capacity in One Health which has a huge untapped poten-
tial. We are just at the beginning of capitalizing on added value of closer
cooperation between human and animal health sectors. The Foundation is
certainly the leading grantmaking institution in shaping this and its position
is challenged only by the Wellcome Trust. 
n Executive Summary
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Rockefeller Foundation Disease Surveillance Networks Initiative
Disease surveillance encompasses disease outbreak investigation in addi-tion to establishing and evaluating programs for prevention and control.
The Foundation is a networking pioneer, supporting network development
since 1993.1
The overall objective of the Foundation’s Disease Surveillance Networks
(DSN) Initiative is to strengthen technical capacity at the country level for
disease surveillance and to bolster response to outbreaks through the sharing
of technical information and expertise.2 It supports formalizing collaboration,
information sharing and best practices among established networks as well 
as trans-national, interdisciplinary and multi-sectoral efforts, and is experi-
enced in developing and fostering innovative partnerships.3 In order to more
effectively address disease threats, the DSN has four key outcome areas: 
(1) forming and sustaining trans-boundary DSN; (2) strengthening and
applying technical and communication skills by local experts and institu-
tions; (3) increasing access and use of improved tools and methods on infor-
mation sharing, reporting and monitoring; and (4) emphasizing One Health
and transdisciplinary approaches to policy and practice at global, regional
and local levels.4
The Foundation invested $21.3 million dollars to strengthen and connect
DSN.5 6 It was seen as a facilitator and partner rather than a decision maker,
and collaborators were treated as equal working partners. A delineation of
possible Foundation exit strategies was communicated in the DSN Initiative
Approval document.7 The longer-term intended focus of the Foundation will
be on national and regional surveillance and response systems to increase
resilience and access of poor and vulnerable populations and to strengthen
cross-border collaboration.8
DSN Initiative in Africa
The DSN Initiative’s global and Africa activities had their origin in 1996 
in a series of consultative meetings held on the prevention and control of
emerging and reemerging diseases at the Foundation in New York, with key
players from the Communicable Disease Cluster of the World Health
Organization (WHO), the Centers for Disease Control and Prevention
(CDC), the WHO African Regional Office and the Global Health Council.
Two project proposals aimed at strengthening surveillance and response
capacity were elaborated. 
1.1
1. Introduction
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Increased interest in disease surveillance in the late 1990s was the stimulus
for cooperation between Asian and African countries on different programs
for controlling infectious diseases with high epidemic potential. The inte-
grated approach for communicable disease surveillance was adopted by
African countries in 1998, and an inter-country cooperation plan was devel-
oped. The Foundation’s DSN Initiative in Africa was formed nearly 10 years
after the 1998 WHO-AFRO integrated disease surveillance agreement and
earlier Foundation engagement in the Mekong region. Core concepts, best
practices, experiences and methodological strategies and approaches tested in
the Mekong region have been adapted and applied to the East and Southern
African setting.9 Africa DSN grants support capacity building (at the aca-
demic, governmental and community levels) and the strengthening of cross-
border DSN with thematic foci on ICT and One Health. The first African
grant was awarded in November 2007, followed by ten subsequent grants in
2008 and 2009.
Purpose and Objectives of the Evaluation of the DSN Initiative 
in Africa (terms of reference)
The purposes of the evaluation were learning and accountability:
[1] Learning from the experience of DSN investments in Africa to inform
the work and strategy of the Foundation, its grantees and the broader
field of disease surveillance. More specifically, the evaluation informs
future directions and strategies for current areas of Foundation initiative
work, particularly in Africa, as well as highlights potential new areas of
work and strategy; and
[2] Accountability to the Board of Trustees, staff and Foundation stake-
holders for the DSN funds invested in the DSN Initiative in Africa.
The main objectives of the evaluation were:
[1] To assess the relevance, effectiveness, efficiency, influence and sustain-
ability of the Foundation’s support to the work of the Disease Surveil-
lance Networks Initiative in Africa.
[2] To assess the underlying hypothesis of the initiative that robust trans-
boundary, multisector and cross disciplinary collaborative networks lead 
to improved disease surveillance and response. Specifically, improved sur-
veillance and response will include assessment of accuracy of information
(in person, place, time) as documented by surveillance assessments, or 
outbreak investigations during the term of the DSN Initiative. The evalua-
tion will not undertake formal disease surveillance system evaluation, but
will exploit secondary data sources for such assessment.
1.3 
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[3] To make forward-looking recommendations to the lead evaluator and to
the Foundation on:
u The implications of the achievements, challenges and lessons from the
DSN Initiative in Africa for the strategy and work of the Foundation in
Africa. This could include lessons for specific fields of work (health, urban,
climate, etc.) as well as lessons for initiatives and grantees that aspire to
build and sustain networks, build capacity, and influence policy in Africa.
u Priority linkages and synergies for DSN learning to benefit the Founda-
tion’s Africa Regional Office, the work of other Foundation initiatives in
Africa, and key Foundation partners in Africa.
u Key priorities for funding and partnerships to sustain the gains made by 
the Foundation in the field of disease surveillance networks in Africa.
The evaluation also aimed to contribute to the field of philanthropy by
demonstrating the use of evaluations in grantmaking, learning and knowl-
edge management, and by informing the field of development evaluation and
assessment about methods for assessing complex networks.
Evaluation Matrix and Evaluation Criteria 
The main evaluation criteria and key questions covered in the evaluation 
and the component studies are detailed in the evaluation matrix (Annex 1).
The matrix used in the Africa evaluation was adapted from the matrix used
in the Mekong region, together with the Global Evaluation Team, during an
inception meeting held in Nairobi in August 2010. The Africa matrix was
also harmonized with the global matrix by relating respective question codes.
Adaptation involved consideration of the outputs of selected grants. The
main evaluation questions are outlined in the following sections.
Relevance 
Relevance includes rationale, niche, role, comparative advantage and value
added of the Africa initiative. Questions related to the extent of relevance of
the initiative to: (1) state-of-the-art/leading-edge thinking and trends in dis-
ease surveillance and response; (2) areas of work of the Foundation in
Africa; (3) stakeholders in the region; (4) occupation of a niche and leader-
ship role; and (5) comparative advantage in disease surveillance in East and
Southern Africa.
1.4 
1.4.1 
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Effectiveness
A substantial part of the evaluation questions referred to “effectiveness,” assess-
ing the results of the initiative in Africa. This includes analysis of the products
and services planned and provided, changes or outcomes that have occurred,
and the impact the initiative has had on people and systems in Africa. 
The evaluation explored (1) the Africa strategy of the DSN Initiative and its
relation to the overall Foundation strategy; (2) the contribution of individual
grants to the overall DSN strategy; (3) the degree of achievement of the over-
all DSN Initiative’s objectives and purposes within the Africa component
(improvement of human resources in disease surveillance, fostering of regional
networks and collaboration, and bridges between regional and global monitor-
ing efforts); (4) the outputs and quality of the selected grants; (5) the major
outcomes of the DSN Initiative’s work in Africa and its contribution to trans-
boundary DSN; (6) the evolution of individual-to-regional and scientific
capacity building; (7) the innovations in ICT tools and methods; (8) the
increase in transdisciplinary One Health leadership; and (9) the contribution
of the DSN Initiative to policy influence. 
Sustainability
Sustainability looked at the extent to which the DSN Initiative can develop
both financial and/or institutional supports to continue the work started in
Africa. Questions referred to evidence that the results of the African grant
portfolio activities will be financially and institutionally sustainable: (1) coor-
dination of grants with national and regional strategies; (2) continuous part-
nering in activities with other country institutions (universities, NGOs, and
governments); (3) reflection of the One Health priority in governance struc-
tures; (4) consideration of strategies for sustaining long-term change (part-
nerships); (5) engagement and motivation to sustain the work; and (6) the
exit strategy and the contribution of the Foundation to leverage resources
and support from other donors. 
Impact
The impact section considered the contribution of the DSN Initiative to 
evidence of influence on the lives and health of people. Indications were 
(1) the reduction of morbidity or mortality in humans, livestock or wildlife;
(2) increased fertility in animals; (3) enhanced surveillance function (early
detection, investigation or control of outbreaks); and (4) cross-border 
collaboration. Impact also related to changed behaviors that have a high
probability for improving lives when sustained. 
1.4.3 
1.4.4 
1.4.2 
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Efficiency
This area investigated the use of resources to obtain results. To what extent
did the Foundation use best management, leadership and governance 
practices? Were those practices cost-effective? Were monitoring, learning 
and adaptation incorporated into the initiative? Were risk management
approaches considered?
Efficiency also examined (1) the “catalytic effect” of Foundation resources;
(2) the alignment of funds and time to outputs/outcomes; (3) development
of and capacity to work with others; (4) the leveraging of resources for indi-
vidual countries; (5) the exchange of information; and (6) process efficiency.
1.4.5 
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Evaluation Components
The evaluation of the DSN Initiative in Africa was composed of threeparts. The first was a portfolio review related to the evaluation criteria
with available documents of the selected grants. The second was a site visit
(three-country study) based on the portfolio analysis and was conducted to
interview staff at the Foundation’s Africa Regional Office in Nairobi, plus
grantees, stakeholders and other actors involved in DSN. (This allowed for
confirmation of the desk analysis and collection of complementary informa-
tion.) The third, based on the portfolio review and the site visit, was a One
Health analysis done to assess the extent of One Health in the grants and to
contribute to the One Health landscaping to inform the Foundation’s future
strategic position.
Grant Selection and Portfolio Review 
Grant Selection Procedure
The Africa DSN evaluation grant basket included a total of 11 grants. A pur-
posive consensual sampling from the grant list was done by the Africa Evalu-
ation Team together with the Global Evaluation Team during the inception
meeting. Grants with duration of activity allowing for maturity were more
complete and thus preferred for evaluation. Grants made in 2009 or later had
lower selection priority. In addition, the animal and human health sector
proportion balance was considered. The selection of grants was made repre-
sentative to the aims of the DSN Initiative which may have caused a slight
bias toward positive outcomes to the overall DSN strategy. A participatory
epidemiology grant was selected because it, unlike most, involved civil soci-
ety. One Health as an important focus of the evaluation influenced the
choice toward those addressing One Health. The grant to the Wildlife Con-
servation Society, considered as already examined during the global evalua-
tion, was reviewed through portfolio analysis by the Africa team.
Selected Grants
Selected were six Foundation grants implemented in Africa in 2007 and
2008. The seventh, initiated in early 2009, was related to an existing grant.
Kenya
[1] 2008 DSN 303, International Livestock Research Institute (ILRI) 
Participatory Epidemiology 
2.1 
2.2
2.2.1 
2.2.2 
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Uganda
[2] 2008 DSN 307, Regional Universities Forum for Capacity Building in
Agriculture, Trans-boundary Animal Diseases 
[3] 2008 DSN 308, Makerere University School of Public Health, Uganda,
Public Health Training 
Tanzania
[4] 2008 DSN 310, Sokoine University of Agriculture (SUA), Morogoro,
One Health disease surveillance 
[5] 2009 DSN 305, SUA, Morogoro, Mobile Technologies, One Health 
[6] 2008 DSN 312, East African Community (EAC), Arusha, Cross-border
human and animal disease prevention 
Southern Africa
[7] 2007 PAN 210, Wildlife Conservation Society, New York 
Site Visit: Three-country Study
Objectives 
The three-country site visit in Kenya, Tanzania and Uganda was planned for
conducting in-depth interviews with the Foundation’s Africa Regional Office,
principal investigators (PIs) and stakeholders. Additionally, it served to com-
plete the collection of source documents for the portfolio review.
Specific objectives were: 
[1] To assess the relevance, effectiveness, efficiency, impact, degree of influ-
ence and sustainability of the grants received by institutions in Kenya,
Tanzania and Uganda.
[2] To determine how the DSN grants in a single country have affected the
disease surveillance systems in the other study countries.
[3] To determine the perception of the grantees, stakeholders and other
actors in disease surveillance on the role and niche of the Foundation 
in disease surveillance in Africa.
[4] To complement the desk review with interviews on questions that could
not be answered by the desk analysis.
Country Selection 
Based on the criteria for selection of grants, the Africa DSN Initiative evalua-
tion focused on an in-depth study of three countries in the region: Kenya,
Tanzania and Uganda. Rationales for the countries selected were: 
2.3 
2.3.1 
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u DSN grants in these three countries were received and were either closed or
were well advanced in activity to allow for assessment of project outcomes.
u Kenya, Tanzania and Uganda were all direct recipients of most DSN grants.
u Kenya was the major regional country, hosting a large number of regional
and international organizations involved in disease surveillance.
u Kenya shares borders with Tanzania and Uganda, including part of Lake
Victoria, a transportation route between the three countries.
u Nairobi, the capital of Kenya, is the location of the Rockefeller Foundation’s
Africa Regional Office.
u The choice of the three countries allowed for verification of cross-border
collaboration in disease surveillance.
Stakeholder Identification
An initial stakeholder map was created during the inception meeting. This
was expanded using a three-pronged approach: 
[1] Grant holders were asked to identify key stakeholders. 
[2] Stakeholders were identified from the desktop portfolio analysis. 
[3] Additional key persons were proposed by grantees and stakeholders dur-
ing the interviews. These additional persons were spontaneously inter-
viewed when possible.
Stakeholders and key persons were ultimately selected according to their
availability around the site visit schedule. 
Design and Pre-testing of Interview and Focus Group 
Discussion Guides
The interview guides were developed by team members from the APHRC
and Swiss TPH during a workshop conducted at Swiss TPH. Two separate
interview guides (Annex 3) were designed, one for the Foundation’s Africa
Regional Office in Nairobi and a second for PIs and stakeholders. Interview
questions were derived from the evaluation matrix (Annex 1). A few ques-
tions about the future of DSN in Africa, posed by the Global Evaluation
Team, were included. Interview guides for each grantee were completed with
any specific questions that emerged during the portfolio analysis of their
grant. The guide for grantees and stakeholders covered an introduction sec-
tion explaining the purpose of the evaluation, the reason why the person was
selected, and the estimated interview time. The query sections started with
two questions asking the grantee to provide a short summary of the project,
the project objectives and what was achieved, and highlights and challenges
2.3.3 
2.3.4 
n Evaluation Methodology
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encountered. The next questions were summarized from the matrix and strat-
ified into six core sections concerning (1) general questions on the effective-
ness of the Africa DSN Initiative; (2) grant-specific networks, partnerships
and capacity-building; (3) ICT within the grant; (4) effectiveness and sus-
tainability of grant-specific outcomes; (5) efficiency within the grant project
and the Foundation; and (6) One Health. The final part of the questionnaire
included an outlook on the future of DSN in Africa. An internal pre-test
with two hypothetical stakeholders was conducted during the workshop and
the guide was amended based on inputs. Guides for focus group discussions
(FGDs) were adapted by the team from the “standard interview guide” in
advance if possible or ad hoc when necessary.
The following protocol was used for interviews:
u The Foundation’s Africa Regional Office staff and grantees were asked a
maximum or the full range of questions from the guide, depending on
their time availability.
u For stakeholder interviews, core areas of stakeholder expertise were identi-
fied in advance and questions from the guide were prioritized, adapting
them for clarity when necessary.
u A guide for FGDs was developed based on areas of expertise of the 
participants.
u During interviews, tasks of the team were shared. The interviewer led
through the questions, the other team member(s) recorded the conversa-
tion, took notes and assisted when clarification was needed.
u For some interviews, the team was split. Teams were composed of (1) at
least one person with experience in interviewing, and (2) one team mem-
ber from APHRC and one from Swiss TPH.
u Before each interview, permission to record the conversation was granted.
Field Visits: Interviews, Focus Group Discussions and Site Visits
Field visits to the three selected countries enabled the evaluation team to
conduct interviews and FGDs with PIs and stakeholders, to gather relevant
source documents for the grant portfolio review, and to observe work prac-
tices at the sites (health districts and facilities) and utilization of ICT tools.
The field team was composed of Swiss TPH and APHRC members of the
Africa Evaluation Team. A profile of the field visits is provided in Annex 2.
The field visits started in Nairobi, Kenya with a briefing meeting and prepa-
ration of FGD guides at the APHRC office. The ILRI grant (2008 DSN
303) included interviews with the PI and key stakeholders (coordinator 
of the Participatory Epidemiology Network for Animal and Human 
Health (PENAPH), the National Consultant Veterinary Epidemiologist
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Trans-boundary Animal Diseases, the Food and Agriculture Organization of
the United Nations (FAO), and the Emergency Centre for Trans-boundary
Animal Diseases (ECTAD) Regional Unit. Also in Nairobi, a stakeholder
(the head of the Division of Port Health Services at the Ministry of Health)
from the East African Integrated Disease Surveillance Network (EAIDSNet)
(2008 DSN 312) grant was interviewed. An interview focusing on the the-
matic area on relevance was held with the head of the Foundation’s Africa
Regional Office and the administrative program manager. The team traveled
to Kampala, Uganda to meet with the PI and collaborators of the Health
Emergency Management Project (HEMP) (2008 DSN 308) grant at the
School of Public Health at Makerere University. The office of the Regional
Universities Forum for Capacity Building in Agriculture (RUFORUM)
(2008 DSN 307) was visited, and there, a FGD was held with the deputy of
the PI at the secretariat and three research grant students. Near Kampala, a
semi-urban health district was visited for a FGD conducted with district-level
stakeholders who attended HEMP training. 
Part of the team stayed in Kampala to complete interviews and FGDs with key
persons involved in the HEMP (trainers of the HEMP, IT manager of the
School of Public Health at Makerere University, and the project technical advi-
sor). The other team members traveled to Arusha, Tanzania, where they met
with the grant holder (principal health officer of the EAC Secretariat in
Arusha) for the EAIDSNet grant (2008 DSN 312) at the offices of the EAC.
Interviews were held with three stakeholders: the director of the Animal Health
and National World Organization for Animal Health (OIE) in Burundi; a pro-
fessor of virology specializing in trans-boundary animal diseases and zoonoses
at the University of Nairobi; and the assistant director of veterinary services
and national avian influenza coordinator at the Department of Veterinary Serv-
ices at the Ministry of Livestock in Kenya. All three were attending a regional
expert meeting. Also interviewed in Arusha was a stakeholder: the head of the
Tanzania Wildlife Research Institute (TAWIRI) for the grants to the Southern
African Centre for Infectious Disease Surveillance (SACIDS) (2008 DSN
310/2009 DSN 305). Next, the team traveled to Dar es Salaam. At Sokoine
University of Agriculture (SUA), located in Morogoro, Tanzania, a FGD was
held with three stakeholders involved in the two SACIDS grants: the ICT spe-
cialist based at SUA and two postdoctoral researchers, based respectively in
Morogoro, Tanzania and Kinshasa, Democratic Republic of Congo (DRC). In
Dar es Salaam, the team split to interview three additional stakeholders: the
head of the epidemiology section at the Ministry of Livestock, the head of the
Epidemiology Department at the Ministry of Health, and a veterinarian and
senior researcher at the National Institute for Medical Research (NIMR) who
specialized in infectious disease surveillance. A site visit was also made to a
semi-urban health district. 
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Data Collection and Management 
Portfolio Review
The following methodological procedure was used for the portfolio review.
All available project documents, publications, manuals, and correspondence
related to the grants were screened. Documents containing information rele-
vant to matrix questions were studied for content responding to queries of
key performance areas. Relevant content was entered, with a source reference,
into an extended Microsoft® Excel version of the matrix, and related to
research question coding from the global evaluation. Data collection for the
evaluation was as follows: (1) documents obtained from the Foundation’s
SharePoint site, grant holders, the Internet (publications) and other sources
were stored on an internal server at Swiss TPH, where access was restricted 
to Foundation evaluation team members; and (2) source documents relevant
for portfolio review performed by the APHRC evaluation team were up-
loaded to a Google site accessible by the entire Africa Evaluation Team. The
portfolio review considered source documents and publications received by
November 30, 2010. Excel files from the portfolio review of each grant were
converted to PDFs for inclusion in the qualitative analysis.
Transcription of Interviews 
The interviews and FGDs were recorded on handheld IC recorders (Sony ICD-
PX820, San Diego, California, U.S.A.). All recordings were fully transcribed
using audio transcription software (f4 V3.1.0®, www.audiotranskription.de). 
Quality Control
To ensure data quality and minimize bias in the conduct of the evaluation,
several measures were implemented during data collection. During the port-
folio analysis, excerpted content was referenced to the source. Each grant
portfolio was reviewed by two evaluators. 
It was clarified to all interviewees that the evaluation focus was on the Foun-
dation’s DSN Initiative rather than the disease surveillance systems of the
countries. This was important to maximize objectivity of the beneficiaries and
stakeholders. All interview transcriptions were reviewed by a second person.
Interviews transcribed by APHRC team members underwent quality control
by a Swiss TPH team member and vice versa. The variety of data collection
sources that were utilized enabled validation of findings through triangulation. 
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Analysis of Data
Qualitative data analysis software (Atlas.ti® GmbH, version 6.2, Berlin, Ger-
many) was used to code quotations in relevant sections of portfolio analysis
summaries, project documents and field interview transcripts. Codes were
generated from key words selected in the evaluation matrix, down to the
third level (sub-sub questions). This approach was chosen in order to facili-
tate harmonization with the global evaluation report. Code lists were shared
with the Global Evaluation Team. Three evaluators developed hermeneutic
units that included two or three projects each. Four evaluators summarized
all quotations, code by code, within hermeneutic units (phase one). In phase
two, four evaluators summarized the phase-one data within codes, but across
all hermeneutic units. The third phase of the analysis consisted of four evalu-
ators repeating the phase-two work of another evaluator, for quality control.
Reflections on the Evaluation Method
The Swiss TPH-APHRC team collaborated well with the Global Evaluation
Team. Exchange visits between Swiss TPH and APHRC were efficient and
fruitful because next steps could be planned together. This evaluation allowed
for building of capacity at both institutions and for the transfer of technol-
ogy through using new text analysis software tools. Foundation video confer-
ences allowed for alignment with all involved at the Foundation’s
headquarters, the Foundation’s Africa Regional Office and the Global Evalua-
tion Team. The Africa Evaluation Team also benefited from the experiences
of the Mekong Evaluation Team. The Africa Evaluation Team was very well
received by interviewees and grantees provided generous support to the team.
The matrix provided a highly structured framework for the evaluation. How-
ever, the granular detail resulted in some redundancy across key questions.
For example, capacity building and collaboration were addressed under mul-
tiple key questions. 
2.3.8 
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The sections below summarize the relevant findings, following the structureof the Africa DSN evaluation matrix. The matrix questions in Annex 1
have been renumbered to reflect the numbering in this chapter by adding “3”
as a prefix. 
Relevance 
Concept
The general philosophy of the Foundation focuses on social and systemic
dimensions of health10, unlike the more “technocratic”-oriented philanthropy
of other U.S. institutions. The DSN Initiative in Africa, a corollary of the
DSN Initiative in the Mekong, addresses the lack of capacity to detect and
respond to recent emerging diseases spreading across national boundaries.
Many of these are of zoonotic origin, requiring a cross-sector human and ani-
mal health approach.11
Rationale and Relevance
Global consultation processes with governments, international organizations
and other donors, such as the Bill & Melinda Gates Foundation, preceded
the launching of DSN activities in the greater Mekong region of Southeast
Asia. This was also facilitated by regional cooperation agreements including
the WHO-AFRO promotion of the Integrated Approach for Disease Surveil-
lance and Response beginning in 1998. Africa DSN projects are divided into
two streams, one developing surveillance methods (such as participatory epi-
demiology and the use of information technology) and the second emphasiz-
ing capacity building in the field of emergency response and regional disease
surveillance (such as SACIDS and Animal and Human Health for the Envi-
ronment and Development—Great Limpopo Transfrontier Conservation
Area or AHEAD-GLTCA). They were relevant to transdisciplinary disease
surveillance12 and to existing regional frameworks (resources are lacking for
strengthening systems). They also addressed issues that were relevant to stake-
holders in the region.13
Situation Analysis
There is an articulated situation analysis in Foundation documents,14 and in
project documents and interviews, referring to the lack of adequate surveil-
lance and diagnostic capacity. Newly occurring outbreaks have often cat-
alyzed interactions between governments and between different sectors, but
surveillance without response capacity and feedback to the source weakens
reporting. Gaps in service delivery and training, response to regional zoonotic
and epizoonotic diseases, and emergency preparedness were identified by
3. Findings 
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some of the projects. In other cases, the first phase of grant work included
interaction with stakeholders resulting in key input, particularly for identifi-
cation of geographical study areas.15
Logic 
The DSN Initiative in Africa builds on regional agreements for an integrated
approach for disease surveillance and complements the global activities that
encompass all areas where the Foundation is active.16 It is based on a para-
digm of growth with equity, “smart globalization,” and attempting to ensure
that poor and vulnerable populations access the benefits of globalization. The
DSN Initiative in Africa has profited from the presence of the Rockefeller
Foundation’s Africa Regional Office and the move of key staff to Nairobi.
The DSN Initiative in Africa has been adapted to the local context, e.g. by
including a focus on wildlife issues (AHEAD—GLTCA), which has not been
addressed in the DSN Initiative in Asia. PENAPH has been connected to
ongoing activities such as the Pan African Programme to Control Epizootics,
the successor of the Pan African Rinderpest Campaign. Projects relate to and
support existing surveillance networks, initiated by the WHO, such as the
EAIDSNet, which also benefited from Foundation support.
Alignment
This section is covered by the Global Evaluation Team. The DSN Initiative
in Africa is embedded in the Foundation’s Global DSN Initiative and has
been adapted to the African context, e.g. by including wildlife health aspects.
The DSN Initiative in Africa also has linkages to the initiative in Asia, e.g.
EAIDSNet and SACIDS.
User Needs
Projects on ICT development recognized the importance of mobile commu-
nication in geographic areas with poor infrastructure, and the technologies
were highly adopted by local communities. The projects were designed to
address stakeholders’ needs, identified as follows: community use of elec-
tronic reporting systems, EAC notification systems for priority diseases, and
training deficits.
Were Key Stakeholders Involved in Problem Formulation? 
Stakeholder involvement at this stage seemed variable across grants. Some
grantees were highly connected with government authorities. For others,
there was no evidence of stakeholders, with the exception of grant applicants,
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being involved in problem formulation. It was noted that communication
with authorities could be improved. Stakeholders were well included in proj-
ect operations, e.g. the AHEAD-GLTCA (2007 PAN 210)17 project, which
involved stakeholders in annual meetings, allowing authorities and scientists
to have excellent exchanges (J. Zinsstag attended the 2010 meeting in
Hazyview, Mpumalanga Province, South Africa). Stakeholders were explicitly
included in the participatory epidemiology network (2008 DSN 303). The
Foundation maintains comprehensive stakeholder consultations through its
regional offices in Africa and Asia for future program development. The
Foundation could require grant holders to document the stakeholder consul-
tations preceding grant application.
One grant (2008 DSN 308) was based on a situation analysis for each of the
countries involved. Gaps in service delivery and training, response to regional
zoonotic and epizoonotic disease outbreaks, and emergency preparedness
were identified. Projects were designed to address the needs of stakeholders in
the region. The initiative is relevant to existing regional frameworks, as evi-
denced by a stakeholder statement that resources are lacking for strengthen-
ing systems. Proposals reflect robust conceptual thinking. For instance, could
ICT facilitate or overcome the constraints imposed by poor physical infra-
structures and logistics?
Role, Niche and Comparative Advantage of the 
Rockefeller Foundation
The Rockefeller Foundation, originally rooted in Protestant ethics, moved
into a paradigm of science-based social responsibility, strongly influencing
the development of academic social science in North America.18 The Founda-
tion’s general philosophy is broad considering social and systemic dimensions
of health. The Foundation has a wider interdisciplinary approach involving
social science and public health at the grassroots level,19 rather than a focus
on technical “magic bullet” solutions (e.g. the Bill & Melinda Gates Founda-
tion’s program on thermostable vaccines)20 or political interest (e.g. the
United States Agency for International Development’s work is perceived as
politically motivated). The Foundation is unique among funding institutions
in its support for development of DSN globally. Supporting the institutional-
ization of DSN is seen as a potential core area for the Foundation because it
has long-term experience in funding DSN. The investment in disease surveil-
lance is of benefit not only to Africa, but to the entire world. 
The Foundation has a long history of support for university-level capacity
building, regionally and across continents,21 with an innovative rather than a
conventional approach. The range and spread of grants under the DSN 
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portfolio indicate that the Foundation is the major funding organization
involved in disease surveillance in East and Southern Africa. The Foundation
clearly has a niche and comparative advantage in public health and health sys-
tems research, with an emphasis on societal and ecological determinants of
health, including One Health. The global engagement of the Foundation har-
bors potential to enhance its output through networking between continents.
Comparative Advantage
The way the Foundation works with grantees is in a spirit of partnership, 
as compared to the “top-down” relationships of the European Union. 
Advantages of the Foundation cited by grantees were that it has user-friendly
granting procedures and flexibility in grantmaking and handling. The 
Foundation excels at networking, focusing on outcomes, and maintaining a
technical link with grantees. The Foundation tests new ideas with “patience
capital” and a strong convening power, in a culture unconstrained by “fear 
of failure.” The Foundation is perceived as a catalyst in thought leadership,
with a focus on where “gaps” exist and what might stimulate change in global
health diplomacy.
The Foundation is free to invest in areas it recognizes as important because
experts are empowered to carry out practical work without operational inter-
ference. Grantees appreciated having a “working partner” relationship, rather
than an “expert–trainee” relationship. This type of rapport is outlined in
Foundation documents.23 Another big advantage mentioned was the
strengthening of on-site capacity building in the countries using existing net-
works, but also North-South partnership. The Foundation has extensive field
experience nearly worldwide, and its flexibility and independence, without
vested interests, is highly appreciated. The presence of a regional office
affords clear insight into the local situation.
3.1.2.1 
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“The comfort zone is top-down. We conceive it in Europe; We conceive it
in London; We conceive it in Brussels… The Foundation takes trust in
investing in grassroots, but not in isolation.” 22
“Certainly one of the things is that they [the Foundation] look more 
like honest brokers ….The challenge we have today is that …people
sometimes seem to feel that there could be other motives for doing 
certain things.” 24
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Increased institutional and planning capacity is needed across the continent.
Building of on-site capacity increases the likelihood of retaining that capacity
on the continent. A disadvantage cited was that grants are generally small,
not being sufficient to sustain Africa-wide initiatives. Further, there was a
perception of lack of technical expertise to follow up grants when compared
to other grantmaking institutions such as the World Bank and the African
Development Bank (ADB).
Value Added 
Grantees expressed a preference for Rockefeller Foundation funding over
other organizations due to the flexible approach to grantmaking and favor-
able rules of engagement of the Foundation. These factors offer the Founda-
tion a comparative advantage and a lead over other funding agencies, such as
the World Bank and the ADB, especially in the field of disease surveillance.
A particular added value reflecting the Foundation’s innovation is the
strengthening of postdoctoral scientists in Africa. Postdoctoral positions are
uncommon in African universities, and only a few other institutions empha-
size their importance in institution building.
Another comparative advantage is the extraordinary convening power of the
Foundation, with the Bellagio meetings promoting “out-of-the-box” thinking
across sectors. The Foundation, covering health, agriculture and social sci-
ences, has the expertise for an integrated development research approach. A
holistic approach to disease management (One Health), including close inter-
action with communities, national, regional and international institutions
was clearly perceived as “better science.” However, the different sectors
should be further interconnected to generate added value. 
Future Core Areas and Leadership
Disease surveillance networks should be institutionalized to ensure their sus-
tainability. The Foundation is seen in future support for the institutionaliza-
tion of DSN because the Foundation has long-term experience in funding
DSN. One of the grantees sees three leading DSNs that potentially build a
“springboard” for smaller ones: the EAIDSNet in East Africa, the Mekong
Basin Disease Surveillance (MBDS) regional network in East Asia and the
Middle East DSN. The three big networks should be brought together, and
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experiences and lessons should be shared. The Foundation has the capacity to
support this integration. The Foundation should also widen the scope of cov-
erage of DSN and maintain a long-term perspective.
As one of the few funding institutions, the Foundation has a highly credible
One Health engagement and could conceptually strengthen ecosystems
approaches to health. The Foundation could take leadership in integrated
development research by stronger interconnection of its overall program. For
example, the well-established competence and experience of the Foundation
could be engaged in the rapidly growing food security crisis through inte-
grated agriculture-health, One Health and ecosystem-health approaches. The
credibility of the Foundation positions it uniquely amongst U.S. institutions,
with the closest conceptual “competitor” likely to be the International Devel-
opment Research Centre (IDRC) in Ottawa.
Effectiveness
Africa DSN Strategy 
Diseases with pandemic potential affect all populations, so surveillance and
control, fostered by the DSN Initiative, benefit all societies and world regions.
Planning and Strategy
Strategic DSN Initiative documents are few but targeted. The Foundation
follows a flexible strategy, allowing for grant applicants and authorities to
shape the strategic approach. The DSN Initiative in Africa was derived from
the global component of the Foundation’s DSN Initiative with local adapta-
tion, e.g. considering wildlife conservation through integrated understanding
based on innovative interdisciplinary applied research, monitoring and sur-
veillance and ecosystem goods and services. This strategic orientation is simi-
lar to the Canadian IDRC Ecohealth program initiative and the Wellcome
Trust One Health Africa capacity-building initiative. The strategy of the
DSN Initiative is to build on synergies, strengthening capacity so that the
impacts of epidemics are mitigated across all levels.
Contribution to the Overall Rockefeller Foundation Strategy 
The DSN Initiative strategy clearly contributes to the Foundation’s overall
strategic aims of equity and mitigation of negative effects of globalization,
but the theoretical basis to this seemed not well-documented and theoretical
considerations were not noted in grant documents. Little reference to the
One Health publications was noted in Foundation and grant documents.
The DSN Initiative in Africa creates and strengthens South-South-North
3.2.1.2 
3.2.1.1
3.2
3.2.1. 
n Findings
Final 
Evaluation:
Africa
29
n Findings
partnerships26 27 and builds on the existing contributions of the Foundation to
public health in Africa, such as its long-standing support for the master’s
degree of public health program at Makerere University in Uganda. The
DSN Initiative is responsive to regional issues and trends, but appears to be
primarily conceived at an academic level.28 29 There has been some change
over time with regard to an increasing emphasis on cross-sector and transdis-
ciplinary involvement, specifically a One Health perspective.30 31
What do Individual Grants Contribute to the Overall DSN 
Initiative Strategy?
Grantees brought fresh ideas to the Foundation. In this sense, individual grants
contributed to shaping the overall DSN Initiative strategy. The Foundation’s
collaborators attended project meetings and discussed strategic issues. Grant
holders stressed the importance of local ownership, and grant proposals often
stated the aim of involving stakeholders, but there is little evidence to support
that these interactions related to the overall DSN Initiative strategy.32
How Were Grants Selected? 
There was no evidence supporting a formal call for projects. Some grantees
took the initiative to approach the Foundation and were subsequently
funded.33 The Foundation provided funding for grants that matched active
initiatives. The Foundation selected and funded proposals developed by
regional disease surveillance experts34 and was willing to take some risk for
new ideas. There are still inequities among research institutions in their abil-
ity to fulfill grant criteria. Some grants were based on situation analysis,
including consultation of stakeholders at the district level on necessary capac-
ity development. But grant proposals were formulated primarily at an aca-
demic level.35
Achieving Objectives
The key objectives of the DSN Initiative were stated as outcome areas: 
(1) strengthen and sustain DSN networks; (2) strengthen human and institu-
tional capacity; (3) test and apply new surveillance tools; and (4) increase
transdisciplinary leadership in One Health. The East Africa program port-
folio contributed in all stated areas to varying degrees. DSN networks were
strengthened, but the linkages with national authorities remain fragile and
require a carefully planned transition.
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How Do the African DSN Objectives Relate to the Overall 
DSN Objectives? 
The DSN Initiative’s objectives in Africa were harmonized with the overall
DSN objectives and extended to include a focus on wildlife health. The DSN
Initiative introduced innovative approaches to human resource capacity build-
ing (the training of staff at the district level in three countries for disaster
readiness and response,36 field visits for regional network collaboration and
cross-border table-top exercises)37 and scientific capacity building (establish-
ing a community of practice to incorporate scientists at the level of postdoc-
toral fellow.)38 New methods (participatory epidemiology) and technologies
(Android phones and digital pens)39 40 were launched and networking
occurred. However, national surveillance capacity and political support
appear weaker than in the Mekong region and require careful consideration
towards the sustainability of DSN.
Support Regional Networks
The DSN Initiative in Africa clearly fostered regional networks and collabo-
ration. The participatory epidemiology network (PENAPH) was unique in
its strong collaboration in West Africa, where there appears to be little Foun-
dation activity, and it was also connected to the Eastern African Unit of the
Emergency Centre for Transboundary Animal Diseases (ECTADs), which
covers Djibouti to Burundi. The HEMP had outreach (including training
curricula in two languages) in DRC, Burundi and Rwanda, in addition to
being connected to the EAC health desk. SACIDS was conceived as a virtual
center pooling resources around themes and across sectors. Their projects
included extensive collaboration and linked the Foundation grants in Africa,
Southeast Asia and Europe. The AHEAD-GLTCA project served to link con-
servation areas between South Africa, Mozambique and Zimbabwe and
strongly encouraged a One Health approach.41 Stakeholders were positive
about the role regional networks, e.g. EAIDSNet, played in information
sharing between participating countries, particularly with regard to trans-
boundary animal diseases.
3.2.4 
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“That is part of what is driving the SACIDS, the concept of a virtual
center where you pool the resources around themes, and pool resources at
cross sectors, and across administrative boundaries. I think that is one
way we should be doing it in Africa. We can tap into expertise in South
Africa. They are part of us.” 42
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The strong networking history of the DSN Initiative certainly translates into
leverage. However, the quality of networks could not be judged in detail and
they likely rely on individual champions. Individual leaders will maintain
collaboration, but these depend on personalities. A pivotal issue in the future
for DSN is the nexus between projects (generally academic institutions) and
governments (including the connection to national health information sys-
tems), which remains weak.
Bridges Between Regional and Global Monitoring Efforts
Although the grants showed linkages with regional and global networks and
partners, international collaboration was not yet clear or strong. SACIDS 
was regionally connected to EAIDSNet and MBDS and globally to the Global
Outbreak Alert and Response Network and Connecting Health Organizations
for Regional Disease Surveillance (CHORDS). There appeared to be some
overlap with the FAO and WHO, but an advantage through this preexisting
groundwork. SACIDS was also collaborating with European universities and
other Foundation grant institutions such as ILRI, promoting One Health,
particularly a closer cooperation between natural and social sciences. AHEAD
brings together senior staff from the agricultural, conservation, and public
health sectors with managers, researchers, young graduate students and NGO
employees from South Africa, Mozambique and Zimbabwe.43 PENAPH links
African DSN with activities in Shanghai, Indonesia, Japan, Pakistan, central
Asia and South America. There seemed to be overlap between the interna-
tional organizations (OIE, FAO and WHO) in management of disease sur-
veillance, but also signs of ongoing harmonization. High fluctuations of staff
occurred, causing a loss of knowledge about the international and Foundation
institutional landscape. RUFORUM largely covered East Africa, but has
greater potential. There was reference to collaboration with the African 
Field Epidemiology Network (AFENet), also involved in disease surveillance
for epidemics.
Grant proposals aimed to promote existing regional platforms,45 but evidence
that this occurred was lacking at this stage. The networks were seen as an
opportunity for strengthening regional collaboration, for example, a meeting
on contingency plans for outbreaks was held in Arusha the day of the evalua-
tion team visit.
3.2.5 
“We [RUFORUM] would have liked to see the continent covered, but
the project unfortunately is only covering East Africa in this particular
case. What we are doing now is to try and look for other means.” 44
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Outputs of the Selected Grants and Their Quality
Potential outputs of the DSN Initiative’s grantees working in Africa are bene-
ficial to the population if they are of good quality and if they ultimately lead
to improvements in surveillance systems. High quality outputs also benefit
governments by improving the efficiency of information systems, thus allow-
ing governments to control costs through greater efficiencies. 
Capacity Building in Surveillance, Cross-border and Cross-sector 
Collaboration 
Surveillance networks require coordination, basic skills in data management
and diagnostic capacity. Capacity building raises awareness which also
changes the way people think and act. Capacity building has occurred at
individual, community, governmental (district) and academic levels.46 47 48
Scientific capacity has been strengthened at MSc and Ph.D. levels in the
RUFORUM, SACIDS and AHEAD grants.49 The RUFORUM network
approach also brings together young students from all over Africa. HEMP
has trained more than 700 district staff through Foundation funding. Out-
puts achieved included 19 additional trainers (3 per country), 235 disease
surveillance staff trained from 10 countries, and development of a new 
module for the disaster management training curriculum.50 In Uganda, 
personnel from one-third of the health districts have been trained. AHEAD
provided training in wildlife health in Southern Africa at the district and 
village level.51 PENAPH built capacity ranging from the level of scientists 
to community workers, which raised awareness and contributed to the con-
trol of rinderpest outbreaks in Southern Sudan. The “training of trainers”
approach provided substantial leverage and allowed for extension of capacity
building to Francophone West Africa.
The DSN Initiative certainly contributed to the awareness and acceptance of
the One Health approach. Ministries of health have begun to include veteri-
narians in addressing zoonotic diseases. Actual change towards a closer inte-
gration at government level happens, however, more under the pressure of
outbreaks. In Tanzania, information regarding disease surveillance is shared
n Findings
“The lesson over the years is that people change their attitudes. After
three months, bureaucratic approaches change, people become interested
in what farmers know, and they realize this is useful information that
they need to understand. The participatory epidemiology techniques
change people and institutions.” 52
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with the Ministry of Management in order to ensure preparedness for out-
breaks and to make available resources by this Ministry. Some governments
created multi-sector teams in charge of moving forward policies and legisla-
tive background for multi-sector collaboration. A cross-sector national task
force was built in Kenya, including representatives from the Ministries of
Health, Livestock and Internal Security, which elaborated the national action
plan. However, evidence on implementation could not be traced by the eval-
uation team.
Cross-border collaboration seems to be at an initial stage, explained by some
stakeholders as partially due to weak national health systems in the region.53
An example of cross-border collaboration in disease surveillance was the
Kagera Water Basin area, where a demographic health surveillance system has
been established in one of the districts.
Information and Communication Technologies Development
A number of ICT to enhance the functioning of surveillance networks are
being field tested or are in an early stage of implementation. Examples
include mobile communication (Android phones), global positioning systems
(GPS), mobile photography combined with rapid field tests, digital pens, and
hand-held data collection.54 The introduction of such innovative technology
requires operational research to assess their efficacy, adequacy and affordabil-
ity in the local African context, despite their wide application in Asia. 
Published evidence on experiences with these tools is not yet present, and
assessment of the usefulness of ICT for the DSN Initiative in Africa was not
clearly defined in study designs. 
Communication 
Cross-sector communication has been enhanced, but mainly through indi-
viduals, which is not sustainable. There was no evidence of formal communi-
cation across trans-national and cross-sector networks.
Policy Dialogue
Grant work contributed to policy dialogue, but the process of policy change
was at an early stage. Projects were located in the policy cycle primarily in the
area of agenda setting.55 Proposed policy negotiation has not yet occurred.56 57
PENAPH aligns its activities with existing DSN and actively pursues dia-
logue with decision makers and planners. There are also indirect effects by
trained staff in diagnostic labs, academia and at the district level, thereby
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enhancing the professionalism of DSN. RUFORUM directly involves collab-
orators from the Ministry of Agriculture, who use acquired knowledge at the
ministerial level. It was stated that the Ugandan disaster management plan
has been drafted by the prime minister’s office, in conjunction with the
HEMP protocol. SACIDS is closely connected to the ministries in the
respective partner countries.
Efforts in advocating the One Health concept were also made by some stake-
holders with politicians to increase understanding of the concept and to harmo-
nize existing policy frameworks and acts with current disease control strategy. 
Dissemination of Findings
Lack of evidence was one of the weakest points of the initiative in Africa.
Projects developed posters, handouts, teaching materials and Web sites to
communicate their work. The Makerere University School of Public Health
states that the East African Journal of Public Health has been reactivated and
updated, but on January 18, 2011, the most recent online edition was dated
2008. According to a stakeholder, information on epidemics is disseminated
in newspapers to inform the public.
The evaluation team expected to receive a list of peer-reviewed publications
from every grant holder. Instead, a surprising deficit in scientific documenta-
tion through publication was observed, which likely affects policy dialogue
and the visibility of the Foundation. In addition, there was much jargon used
but little solid evidence of an added value of One Health or the effectiveness
of ICT.
“At most of the networks, for the sake of sustainability, there is the
thought that they should be anchored in the regional economic commu-
nities, because the outside funding will not go on forever. Meetings have
been carried out with these people to try to make sure these networks
will remain over time.” 58
“The other thing will be harmonization of some policies and acts. In
Tanzania, we have a number of contradicting policies and acts, which
sometimes probably contributes to inadequate disease-control strategies.
Policy pairing is a priority in most institutions to engage every stake-
holder and every sector when it comes to disease interventions.” 59
3.2.6.5 
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Outcomes 
Outcomes included the introduction of new methods such as risk-based sur-
veillance in SACIDS or advocacy for commodity-based trade in Southern
Africa, a strategy to overcome export restrictions due to endemic foot-and-
mouth disease (FMD) in South African wildlife conservation areas. Outcomes
could also be a change in attitude: e.g. through work done by PENAPH,
indigenous/farmer knowledge has come to be valued by veterinarians.
Trans-boundary DSN
There is increased dialogue and consultation on trans-boundary animal dis-
ease between countries of the EAC through workshops and task forces. Con-
tingency plans currently exist for rift valley fever (RVF), peste des petits
ruminants and avian influenza (AI) in Sudan, Ethiopia and Somalia. Emer-
gency plans have already been activated in small outbreaks. It is difficult to
relate these activities solely to the Foundation’s DSN Initiative, but clearly, it
has contributed. This is a long-term engagement. EAIDSNet, with funding
from the Foundation, initiated the implementation of community-based
integrated human-animal disease surveillance in cross-border settings through
advocacy, identification, recruitment and motivation of local volunteer com-
munity health workers and linked them to the National Human and Animal
Integrated Disease Surveillance and Response System.60
The HEMP project provided statistics from trainings, including numbers of
provincial officials from Kenya, DRC and Rwanda who had been trained in
emergency management. By November 2010, 235 participants from 10
countries had received training and developed operational plans for disaster
management. An extensive training curriculum manual was developed in two
languages.61 However, the evaluation team received no information on the
three planned publications for 2010, and the HEMP Country Progress
Report for Rwanda was only two pages, indicating a weakness in documenta-
tion. SACIDS is building a network of high-level institutions from the South
and North that are involved in pandemic response. Africa-Asia exchanges and
collaboration were fostered, to benefit from best practices.62 63
Capacity Building 
Human resource capacity in disease surveillance has been built at commu-
nity, district and national levels. PENAPH introduced courses on participa-
tory epidemiology into university curricula. University-based programs such
as RUFORUM had a high level of leverage by direct training, in addition to
developing small grants for young researchers. Community health workers
3.2.8 
3.2.7.1
3.2.7 
Disease 
Surveillance
Networks
Initiative
36
have been identified and training, including both the human and animal sec-
tors, has been initiated in some districts.64 However, in other areas, there have
been delays in developing the training materials due to local language transla-
tion issues. District teams have been trained in disaster and disease outbreak
management through the HEMP grant. District and national personnel have
benefited from the emerging infectious disease table topic, and field simula-
tion exercises have been held in Kenya and Uganda. There was no informa-
tion on quality control of new capacity in disease surveillance and no
indication of any accreditation process.
Institutional Capacity Building
Institutional capacity has increased. The coordination of EAIDSNet was trans-
ferred from NIMR to the health desk of EAC. Training curriculum modules
on zoonotic disease surveillance have been included in master’s degree of public
health programs. District disaster management plans have been developed, but
the process of integrating them into policy is still ongoing. Stakeholders noted
that limitations to institutional capacity still exist in the area of data manage-
ment and infrastructure weakness, especially laboratory capacity.
n Findings
“Many of the people we have trained over the years are now leaders in
their countries: directors of veterinary services, senior officers, and interna-
tional consultants.” 65
3.2.8.1
“….there is a zoonosis technical group meeting where I participate.
Kenya’s Ministry of Livestock Development, through its Department of
Veterinary Services and the Ministry of Public Health, come together and
share information through this technical working group. They had some
resolutions and a way forward for them to work together by sharing infor-
mation… they embraced the issue of One Health.” 66
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New Tools and Methods (information and communication 
technologies)
New mobile technologies, approaches and tools are promising in enhancing
the flow of information, and in promptness of capturing disease events, and
in reporting regarding disease alerts.67
Communication between different country teams was reported to have
improved due to ICT support in the form of servers and internet infrastruc-
ture. Under grant 2008 DSN 308, the e-learning server was relocated from
Europe to Makerere University, resulting in increased local ownership and
facilitating access to learning materials on the network by trainers and partic-
ipants.69 Several stakeholders mentioned the weakness of the HMIS, and the
importance of strengthening them as a primary source of health information.
Reporting was felt to be improving with innovation in ICT, such as digital
pens. However, capacity in disease surveillance and laboratories still needs to
be built and strengthened in the near future. At the regional level, it was
mentioned that the EAC Secretariat needs to build its capacity to rapidly col-
lect and share surveillance information directly with member states, rather
than through the WHO. Leverage momentum potential was noted in one
project where unique access to national disease data was facilitated through
an arrangement with the Ministry of Health.
New Devices
New mobile and ICT were field tested in many of the grants. Geographic
information systems, as new ICT, were introduced and used by grantees at
academic, ministry and district levels. The 2008 DSN 310 and 2009 DSN
305 grants have tested a manual and the Android mobile operational system
technology in animal and human health sectors for the collection of disease
surveillance data.70 71 The project used an official system and arranged with
3.2.9.1 
“The mobile technologies are serving to overcome the constraints of poor
physical infrastructure in Africa and Asia by real-time transmission of
clinical observations at the point of disease outbreak (be it in communi-
ties, health facilities, on the farm or in wildlife) to experts at district,
provincial or national headquarters, and the feedback (i.e. response) from
such expertise to the point of outbreak, also in near real time. It is a tech-
nical empowerment of the primary health (human or animal) responders,
who in Africa are invariably sub-professional or even auxiliary cadres.
This is a clear example of technology that is fit for the purpose.” 68
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the Ministry of Health and the Ministry of Livestock to report on ten prior-
ity diseases for human and animal health.72 Android cell phones were tested
at health facilities of pilot districts for completing and transmitting electronic
routine disease reports to the next higher level, and at the community level
with trained “community-based reporters.” Mobile technologies were tested
in different ecosystems such as the Ngorongoro, Kagera River Basin cross-
border areas (Burundi, Rwanda and Tanzania) and in the Zambezi River
Basin (Zambia).73 74 In addition, Web applications (EpiCollect) were used for
data transfer from cell phones to Microsoft Excel® and available open-source
tools were tested for the Android platform.75
Cell phones and GPS recording were used for FMD surveillance in Uganda
by RUFORUM. A surveillance system is in place in the Ugandan health sys-
tem where outbreak information can be sent by SMS. In addition, geo-
graphic information systems (GIS) and mapping tools were introduced at the
health district level for mapping purposes (e.g. collecting geographical coor-
dinates of health facilities and other features using GPS), and elementary
data management in pilot health districts in Tanzania and DRC. Another
new method, simulation modeling, was tested on lion biology by AHEAD.76
Transdisciplinary—One Health
The Foundation emphasizes cross-sector One Health and transdisciplinary
approaches in its DSN Initiative and the reviewed grants focused on develop-
ing capacity in these areas. The term “transdisciplinary” is not further 
specified (e.g. by referring to a textbook definition) in Foundation or grant
documents.77 We suspect there is confusion between what is considered 
interdisciplinary (collaboration between scientific disciplines) and transdisci-
plinary (the connection between science and society, e.g. between academic
and non-academic knowledge and actors). In this sense, participatory epi-
demiology and policy dialogue are most closely related to transdisciplinary
theory. PENAPH grew out of participatory rural appraisal methods and ben-
efited from a large body of practical knowledge of communities in the field.
The project recognized the importance of understanding the people’s real
needs. PENAPH initiated training of medical doctors and veterinarians. Fur-
ther linkages were established with the wildlife sector. This is a unique fea-
ture of the DSN Initiative in Africa. 
One Health as a concept is also not specified in written documentation, and we
found no reference to published concept papers.78 79 80 Interviewees gave rather
operational definitions, and there is no clear strategy that would delineate and
guide activities. One of the challenges in advocating the One Health concept in
the local population is the appropriate translation into local languages.
n Findings
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As a working concept, we consider One Health as any added value of closer
cooperation between human and animal health, as compared to both sectors
working individually. In this context, the added value of One Health is 
accelerating information about outbreaks of zoonoses such as RVF; saving
resources from working together on AI or rabies; or sharing infrastructure,
laboratory resources and joint interventions between sectors. Some inter-
sector collaboration is already practiced in remote areas and other locations
with limited infrastructure (e.g. sharing of cold chains for vaccinations and
laboratories by human and animal health sectors). However, new policies
have not yet been adapted. One of the projects is mapping potential joint
resources that can be shared to raise awareness of improving joint synergies.
The same project is also recruiting a postdoctoral fellow who will more
closely examine health policy and strategies, and how they could be adapted
to address the One Health concept. The control of rabies was cited several
times as an example of success using the One Health approach in Entebbe,
Uganda and Arusha, Tanzania. 
Awareness of the One Health concept has been raised and actions have been
taken at the academic level to form the Higher Education Alliance for Lead-
ership Through Health (www.halliance.org), a network of seven East African
schools of public health. However, One Health still has a huge untapped
potential. It is just at the beginning stage, and the Foundation, challenged
only by Wellcome Trust, is clearly the leading grantmaking institution in
shaping it.
Transdisciplinary and One Health Leadership
The Foundation is the leading grantmaker worldwide for One Health. Pos-
sibly this stems from an open culture of breaking silos between disciplines
towards a united approach of professionals working together. There was evi-
dence from one grant that the transdisciplinary and One Health approach
has become more anchored in research activities. For example, there was
establishment of a “trans-boundary animal diseases working group” involv-
ing different stakeholders from research and academia, government and
3.2.10.1 
“I talked about when you go to a farmer and you are dealing with him.
He has a problem, and it’s difficult to identify, and you are talking
about the multi-disciplinarity of it. When you have people from differ-
ent fields, you are able to better see what the issue really is. Because each
is only looking through one lens. But together, you are able to see
through many different avenues.” 81
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communities, tasked with enhancing national and regional policy respon-
siveness to trans-boundary animal diseases.82 The role of PENAPH was not
institution building, but rather seeding One Health ideas into people’s
minds and facilitating institutional interactions. One grant holder (2008
DSN 312) was considered a leader of One Health in Africa. There was also
leadership in academic reform. Specific One Health master’s degree pro-
grams with joint curricula for human and animal health were developed at
the University of Nairobi and at the School of Public Health and RUFO-
RUM at Makerere University in Uganda.
The One Health emphasis was referred to during the situation analysis for
grant 2008 DSN 308 and also in the outcomes of the projects. The modified
curriculum was developed with a training manual that addresses disasters and
zoonotic diseases, and recruitments have been made at the EAC, where the
terms of reference have included specific responsibilities in “One Health.”
Joint training sessions within the government comprising the Ministries of
Health, Agriculture and Livestock Development became a practice, and 
joint working groups address common issues like zoonotic diseases. Six 
EAC priority diseases at the intersection of human and animal health are
addressed with the One Health approach: tuberculosis, anthrax, trypanoso-
miasis, RVF, Ebola and AI. Formalized regional structures, such as the
National Human and Animal Integrated Disease Surveillance and Response
System, exist to strengthen the transdisciplinary approach to disease surveil-
lance in the EAC.84
RUFORUM has extended cross-sector dialogue to plant and agricultural sci-
entists. AHEAD has used an integrated approach to delineate the practical
risk factors for bovine tuberculosis and other zoonotic disease transmission
between wildlife, livestock and human populations in the study areas in Zim-
babwe, Mozambique and South Africa. Uganda, Kenya and Tanzania have
established functioning inter-sector collaboration at the government level.
One Health capacity building was being advocated in some of the govern-
ments. The Ministry of Health in Tanzania was considering initiation of a
n Findings
“We had a deans’ meeting and the alliance brought together all the other
schools of veterinary medicine in the region to work with us. We have
formed One Health Central and Eastern Africa (OHCEA), a network
that brings together schools of public health and veterinary medicine
amongst the six countries. The secretariat is here, and they made me the
chair of that group. Our objectives are to look at health as one in terms
of human and veterinary.” 83
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curriculum on “Epitrack,” in which epidemiologists from the human and
animal sides would be trained together. The sustainability lies in the assump-
tion that these people have been trained and are working together in the
field, creating a good environment for collaboration. Another example, for
capacity building in the area of One Health in Burundi, is a joint training of
15 laboratory technicians from the Ministry of Agriculture and Livestock and
ten laboratory technicians from the Ministry of Health in polymerase chain
reaction technology for virus detection.
However, the connections seem to be fragile and dependent on external
funding and individual champions. The public health sector maintains reser-
vations. Human resource capacity in terms of number and skills is still inade-
quate because research and surveillance in wildlife is expensive. Interviewees
explained that the One Health concept has not been institutionalized suffi-
ciently and that until there is legislation and institutionalization in govern-
ment and academia (e.g. attending courses in One Health and animal
diseases required for certification of public health specialists), the initiative
will not be successful. It is also recommended that national governments
revise the actual curriculum and develop and introduce adapted policy strate-
gies in order to sustain capacity building in One Health.
Organizational Excellence
There was little information on organizational excellence, but many of the
grantees manage larger portfolios of projects. It was not clear to what extent
their grants were strictly separated. There were definitely overlaps, e.g.
between Rockefeller Foundation and Wellcome Trust grants. The regional
network in East Africa was improving its ability to coordinate responses dur-
ing disease outbreaks, particularly with the use of multidisciplinary and
multi-stakeholder teams managing the responses.
Policy Influence 
Conceptualization of Policy Change 
There was sparse indication for conceptualization of policy dialogue as it is
conceived by transdisciplinary research theory. The evaluation team did not
find reference to theoretical basis of science-to-policy dialogue. Single
grantees held panel discussions with key policy representatives, indicating
awareness of disseminating the right information to the right audience. This
example falls under “agenda setting” in the policy cycle. The project also
shared lessons with the African Technology Policy Network regarding climate
change (policy cycle: policy development).85 Another grantee will assess
researchable policy analysis issues on One Health (evaluation/review of 
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existing policy). A Ph.D. position is foreseen for this investigation, and the
candidate has been identified. A stakeholder workshop is planned to assess
critical researchable policy analysis issues on One Health.86 87
Planning for Policy Influence
There was very little evidence of conceptual planning of policy influence.
Planning for policy influence was rather indirect by training of government
staff, i.e. in One Health. Individuals maintained good contacts with govern-
ment and brought national authorities on board in planning discussions (see
also 3.2.6.4 policy dialogue).
Linking Policy and Practice 
In Uganda, a policy document on disaster management that includes provi-
sions regarding outbreaks of animal diseases was in its final stages. There were
plans to establish an emergency disaster response center within the office of
the prime minister, with representatives from the different disciplines, includ-
ing human and animal health. A high-level team composed of national
health ministers of countries in the EAC and representatives of other health
institutions has been involved in field visits to the Mekong Basin DSN, and
has initiated policy changes such as the establishment of surveillance systems
at international airports in the region.88 Initiatives, mostly from the research
side, were taken to address the One Health concept to policymakers with the
aim of moving forward a unified approach in infectious disease surveillance.
A paper on the conceptual framework of One Health, prepared by
researchers from one of the grantees, has been accepted for publication in
The Lancet Infectious Diseases.89 90
Intended Users and Uses
Intended Users of DSN in Africa 
Users of DSN were diverse: livestock holders and traders, pastoralists, com-
munities, professional organizations, private veterinarians and physicians, all
levels of governmental health systems and international agencies. There was a
lack of public-to-private linkage. The private sector was important in animal
health, but currently has no role in surveillance. Many private field veterinar-
ians could be given mandates for disease surveillance. The issue of feedback
from field work and the importance of strengthening feedback were raised by
many interviewees. This was an example of how users could benefit from
DSN, but evidence of it occurring was not noted.
n Findings
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Intended Uses/Changes of DSN in Africa
Only beneficiaries and benefits of DSN in Africa were mentioned. There was
no example for shaping overall strategies. Beneficiaries of networks noted
were the population (benefiting from well-working systems); governments (in
particular the ministries of health and livestock), and universities (access to
information, methods, approaches, better training). Also mentioned were
African partners benefiting from the knowledge and experience of other
regions affected by emerging infectious diseases (such as H5N1 in Asia) and
experiences in contingency planning, disease containment and community
engagement.91 Community-based cadres were used in disease surveillance,
which may contribute to shaping the overall strategy.92
Uses of DSN cited were improved organizational, technical and diagnostic
capacity in disease surveillance; change of attitude between sectors; accelerated
detection of human and animal disease; and enhanced communication and
faster response. Additional uses were contingency planning for disaster prepara-
tion and outbreak management; strengthened international communication/
reporting; and reduced trade barriers due to effective animal disease control.
Research Capacity 
Very little scientific output existed in the peer-reviewed international litera-
ture. This was clearly a weakness of the DSN Initiative. Rockefeller Founda-
tion grants may not aim primarily at science but rather at development.
However, the profile of the Foundation could rise and be more visible with
high-quality science as a result of the projects. Not all types of work are read-
ily published, but quality presentations were made by PENAPH and
AHEAD members in Belgium and South Africa in 2010, and presentations
are foreseen at the One Health conference in Melbourne in February 2011.
It appears that AHEAD likely had the strongest publication record. 
Research Capacity Building
Postdoctoral fellowships were introduced at Sokoine University of Agriculture
(SUA). This is new for African universities, but is also encouraged by Well-
come Trust. SACIDS, AHEAD and RUFORUM were strongly engaged in
the training of young scientists, but there was not yet much published out-
put. The evidence for scientific output (publications in peer-reviewed jour-
nals) was sparse at this stage when cross-checking publication databases such
as ISI Web of Knowledge, PubMed and others. Researchers (at the Ph.D.
and postdoctoral levels) from some of the grants have prepared manuscripts
for publications, which were in process to be published. Under grant 2008
DSN 308, the East African Journal of Public Health was reactivated, although
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the latest posted material was dated 2008, and public health conferences were
organized, with sponsored presentations on disaster management. There was
to date no evidence of the publication of research work done under any of
the grants. Grantees highlighted the need for greater support for research in
the area of disease surveillance in the region.
There was some evidence for productivity of other outputs such as posters
presented by students and postdoctoral fellows during annual meetings and
conferences. A number of grants publish periodical newsletters (in electronic
form on their Web pages and in paper form), such as Makerere University’s
School of Public Health and RUFORUM. At the secretariat of the EAIDSNet
at the EAC, there was no print material available except for meeting reports
signed by the participants. EAIDSNet intends to produce an electronic bul-
letin, but this has not been accomplished due to lack of personnel. There
seemed to be good collaboration between DSN grantees on the technical
level, but apparently there is also competition between disease surveillance
networks working together. There was collaboration between Asian and
African grantees (e.g. EAIDSNet and SACIDS). A clear research strategy was
not noted in the DSN Initiative in Africa documentation.
In the area of technical innovations and new methods, basic GIS training on
thematic mapping, elementary data management and hands-on practical use
of GPS receivers (as a separate device or integrated in an Android system) for
collecting geographical coordinates of features was an important aspect per-
formed at academic level.94 Use of Android phones, enabling collecting,
entering, storing and transmitting data and information, was another innova-
tive achievement introduced and tested in projects.
n Findings
“One, as a student, I would say that there has been a network among
the students. For instance, there are the Zimbabweans and Ethiopians
who come to one table and share the regular problems and also seek for
solutions together. At the same time, the program has empowered us to
work with communities that really are affected by most of the issues we
are getting globally, regionally and locally. At the same time also, indi-
vidually, our capacity is built. For instance, if I come back later, maybe
I will be promoted to a different level. At the same time, my capacity to
synthesize issues and seek solutions has improved. I think this has been 
a big contribution.” 93
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Sustainability of Initiative Outcomes
Financial and Institutional Sustainability 
Grantees were aware of the need for and were making efforts to assure finan-
cial and institutional sustainability of their programs through the broadening
of funding, as well as national, regional, international, academic and public/
private partnerships.95 96 97 Not all projects were closely linked to national sur-
veillance systems. There were efforts to support DSN by regional bodies such
as the EAC, the South African Development Community, and the New Part-
nership for Africa’s Development and the Economic Community of West
African States. The capacity of grant holders to attract their own funds would
be strong evidence for independence and sustainability. It is equally impor-
tant that new methods and One Health become embedded in academic cur-
ricula. This was achieved at SUA and partially at Makerere University, but
needs further support and effort in other areas. Sustainability in research
would be achieved by establishing young scientists as postdoctoral fellows
and allowing them to develop a research group. Also emphasized was “owner-
ship” of programs and ICT. Efforts were made to evolve from passive users 
to active collaborators in developing new tools and technologies in order to 
fortify regional sustainability. Financial support of the networks by regional
governments was perceived as essential to achieve sustainability, but this is 
yet to be assured.
Rational and Regional Strategies
One of the challenges in sustainability was seen in local ownership in con-
trast to outside donors, particularly regarding conceptual and geographic
scale-up of innovations in disease surveillance. In the pilot phase, external
funding was an advantage to focus and develop relationships, but ultimately
ownership should be taken over by national structures. 
Africa is still dependent on expensive technologies and needs to find ways of
accessing affordable, locally-owned technologies. Servers for data manage-
ment, for example, should be owned and managed internally by the coun-
tries, and not externally. A challenge supporting ownership of ICT and data
management tools within countries is reluctance in the ministries to transmit
health information outside the country. Therefore, efforts are being made to
establish servers and build capacity at the country level, for example in Tan-
zania. A legislative background could be created to better protect ownership,
according to one interviewee.
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The use of fundraising as a strategy for long-term change was not empha-
sized. Possibilities were perhaps perceived as fully exploited. The EAIDSNet
acquired a five-year grant of $23 million from the African Development
Bank for disease control under climate change responses and health. They
also acquired $63.6 million from the World Bank “to establish a network of
efficient, high-quality, accessible public health laboratories for the diagnosis
of tuberculosis and other communicable diseases,” whereas $1.3 million was
allocated for the EAC EAIDSNet. Other suggestions regarding sustainability
included the recommendation that regional networks be coordinated by the
African Union to create cohesion, prevent duplication and improve cost-
effectiveness. There was a preference for long-term funding and an expansion
of the scope of the initiative.
The exit strategy for the DSN Initiative should account for a transition to sus-
tain activities and capitalize on investments. Grant work should be published
in scientific journals recognizing the Foundation’s contribution. Regional
institutionalization, as in the MBDS regional network, e.g. through the
Southern African Development Community (SADC), EAC and the Eco-
nomic Community of West African States, requires more time. The Founda-
tion should consider a five-year extension of the most promising academic
and regional DSNs, and work actively toward their institutionalization. 
According to interviewees with an academic background, ownership of
capacity building might be increased by:
u Africa-based training: The approach of partnering with regional and local
institutions was appreciated and sustainable (south-south cooperation
rather than south-north cooperation).
u Short exposure versus long-term training: Short exposure to interna-
tional research institutions was preferable to long-term capacity building
abroad. Opportunities for students to visit “advanced” institutions were
valuable, as they benefited from seeing the operation of other systems.
u A mixed schedule of courses and work (e.g. in a health district) 
allows acquisition of practical experience, giving students responsibility 
during training.
n Findings
“… we probably have the highest bulk of the most infectious disease in
the world. And therefore, we in this region as owners of that problem,
must own the forces, but not do it in isolation. We have got to interest
others in our problem.” 98
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Impact
Impact on Population Health 
The impact of the DSN Initiative’s grants was difficult to determine at this
stage due to the short time period since the implementation of the activities.
The achievement of some of the desired outcomes suggested that the impact
on human and animal health will likely be felt in the future. Some impact 
of the capacity building components of the grants has been described, 
e.g. response of disaster management teams in Uganda to mudslides in
Bududa near the Kenyan border. One stakeholder suggested that there has
been a reduction in the morbidity of some communicable diseases due to
improved surveillance at district sentinel sites leading to early detection and
treatment. Through participatory epidemiology, some small rinderpest out-
breaks were noted in South Sudan. Sensitization on AI increased reporting.
Better reporting does not necessarily reduce incidence, but understanding of
the disease improves. Despite improved surveillance, the response capacity
remains very weak. 
Reduction of Infectious Disease Rates
Clear evidence for improved population health was not yet shown in most
projects. However, they were in an early stage of implementation. The evi-
dence for improved effectiveness in addressing specific disease threats was
summarized mainly in increased awareness and alertness, and understanding
of the need to share information. 
Indirect improvements were made. For example, in Tanzania, laboratory
infrastructure of research institutions, e.g. the NIMR, has been strengthened
and RVF and AI can now be diagnosed. Tanzania has established surveillance
sentinel sites. These measures have clearly contributed to reinforce the
national disease surveillance system. Research capacity on zoonotic diseases
such as RVF is being increasingly built by engaging Ph.D. students and con-
ducting specific trainings. These skills would be implemented during out-
breaks. Likely, evidence for reduction of infectious disease rates would only
be measured during an epidemic. But the potential for reduction could be
considered. For example, successful investment in surveillance support and
cross-sector exchange of data through the SACIDS network would enable
quick response, thereby reducing disease rates. In another project, communi-
ties improved their response capacity to Newcastle disease in their poultry
flocks,99 which impacted infectious disease rates.
Evidence from the field was considered as important to convince policymak-
ers to enhance policy guidelines in disease surveillance and preparedness.
3.4.1.1 
3.4 
3.4.1 
Disease 
Surveillance
Networks
Initiative
48
One stakeholder considered advocacy as an important catalyst for enhanced
surveillance function, through improvement of reporting systems. There has
been improvement in the reporting system in Tanzania in the last few years,
increasing coverage from 30 to 80 percent. It was felt that advocacy initiated
these improvements.
Efficiency 
Cost Effectiveness 
Grantees agreed that resources were adequate for the initial project goals 
and capacity building. Additional funding would be necessary to support a
broader scale-up phase. In some cases, proposal aims could not be fully
implemented due to cost challenges incurred.100 Single grantees indicated that
the funding for budget line items was small and insufficient to sustain a field
intervention in multiple countries. Cost efficiency could not be assessed
without audits, but delays in project implementation due to lack of competi-
tive proposals and university bureaucracy were mentioned.
Management and Governance 
Current grants were relatively small. The Foundation might examine options
for fewer, larger grants. However, the risk would be greater with larger grants.
Effective Management and Leadership
The Foundation’s management support was perceived very positively. The
convening and networking power of the Foundation was highly appreciated,
and the Foundation’s management support was viewed as less bureaucratic
than with other donors. Grantees also indicated that the Foundation pro-
vided supportive monitoring and review of projects during implementation.
They valued the opportunities the Foundation provided to meet with other
grantees, especially the Bellagio meetings.
Efficient Management
The Foundation’s leadership was perceived as open and relational rather 
than managerial. The grantees expressed satisfaction with the degree of 
flexibility and autonomy offered by the Foundation in decisions regarding
priority areas, allowing for readjustments when challenges were encountered.
Regional office and headquarters staff were thought to be very well-informed
on both the field of DSN and grant-specific knowledge. There was a 
suggestion for the Foundation to strengthen the presence of technical staff on
its team for the coordination of public health portfolios.
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Monitoring 
Monitoring and Evaluation Practices 
There was little evidence that monitoring, learning and adaptation was a
focus of the portfolio. Monitoring and evaluation practices within grants
were informal and not well documented.101 One project held a midterm eval-
uation meeting with key actors.102 Another grant reportedly had an overall
monitoring framework to track progress towards targets set in the annual
operational plan. However, this monitoring framework did not seem to be
followed in practice. 
Risk Management 
There were no formal risk management plans identified.
Management of Programmatic Risks
Risk factors cited included institutional weaknesses, e.g. regarding bureau-
cratic delay processes. Financial risks were related to slow bureaucratic sys-
tems. For example, meetings were organized by the EAC, but participants
from some countries did not receive clearance on time. Some of these risks
were managed through patience and personal and institutional relations. Pro-
grammatic risk also related to lack of project leadership continuity. High staff
turnover was noted at the level of project director. This problem was man-
aged by PIs rather than by the Foundation. Another risk was lack of coordi-
nation of the grant cycle with university academic cycles. The Foundation
was responsive to this problem through flexibility in extending grant deliver-
able timelines.
Risks encountered with capacity development activities were the weak techni-
cal background of participants at the trainings and difficulty with participants
not completing training due to other engagements. These issues impacted the
achievement of the expected training session outcomes. One grant evaluated
the technical capacity and knowledge of trainers. A risk identified in one grant
was failure to implement disaster-management plans, developed during the
training sessions, because this was dependent on funding by ministries. It was
not clear how this risk was managed. 
Proposed Feedback to Participants of the Evaluation
All interviewees expressed a strong interest in the findings of the evaluation
report. The evaluation team would welcome providing feedback to the 
interviewees.
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Introduction 
This document provides an overview of the Scope of Work and the Terms of Reference of the
External Evaluation of the Rockefeller Foundation’s Disease Surveillance Networks (DSN) Initia-
tive in Africa to be undertaken during the period of June 1, 2010 through December 31, 2010. 
Background
In 2008, the Board of Trustees of the Rockefeller Foundation approved $21.3 million in 
support for the Disease Surveillance Networks (DSN) Initiative with the aim of achieving the
following objectives:
[1] Improve human resources for disease surveillance in developing countries, thus bolstering
national capacity to monitor, report and respond to outbreaks;
[2] Support regional networks to promote collaboration in disease surveillance and response
across countries; and 
[3] Build bridges between regional and global monitoring efforts.
Intended Outcomes of the DSN Initiative 
At the initial stages of the Initiative the outcomes were stated as: 
u Improved competencies (skills, capacities) in the Greater Mekong Sub-region and East and
Southern Africa to conduct disease surveillance and response efficiently and improve capa-
bilities in trans-border collaboration across countries;
u Global collaboration and learning among regional disease surveillance networks worldwide; and 
u Collaboration between regional disease surveillance networks and international agencies to
increase the efficiency of global systems for disease surveillance and response.
The recent RF Results Based Framework for DSN provides a clearer articulation of the major
outcome areas of the DSN Initiative. 
u Outcome 1—(Networks). Transboundary disease surveillance networks in Southeast Asia,
and in East and Southern Africa are formed, sustained and evolve to enable disease surveil-
lance practitioners to collaborate, share information, and learn how to more effectively
address disease threats. 
u Outcome 2—(Capacity). Disease surveillance practitioners and their institutions
strengthen and apply and distribute technical and communication skills in disease surveil-
lance to more effectively address disease threats. 
u Outcome 3—(Tools). Disease surveillance practitioners have increased access to, and use
improved tools and methods to effectively and efficiently monitor, share and report infor-
mation, and to respond to disease threats. 
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u Outcome 4—(Trans-disciplinary leadership—“One Health”). Policy makers, human
health and veterinary practitioners take a trans-disciplinary approach to policy and practice
in animal and human health emphasizing the One Health principles at global, regional and
local levels. 
u Outcome 5—Organizational excellence, accountability and learning. The DSN team
operates effectively, efficiently, provides leadership in RF, contributes to the RF Mission, is
relevant and accountable to its stakeholders and learns from its monitoring and evaluation. 
Total DSN Grant Making to Date 
Over four years from 2007-2011 the Rockefeller Foundation, in partnership with others,
intends to help equip developing countries with the tools and human and institutional capaci-
ties to improve disease surveillance and response. Of the total $21.3 million approved for the
DSN Initiative, $16 million has been awarded in 43 grants as of December 31, 2009. The
remaining funds will be awarded in grants in 2010 and 2011. 
u Africa: Of the $16 million awarded to date, a total of $4.5 million has been awarded for
DSN work in Africa: $3.5 million to institutions in Kenya (3), Tanzania (3) and Uganda
(2), with an additional $1 million awarded to northern institutions working on disease sur-
veillance and related issues in Africa. 
u Global: Grants totaling $2.5 million have been awarded to institutions in the U.S., Canada
and Europe for related work that is global in scope. 
u Asia: Grants totaling $9 million have been awarded to institutions in Asia, including some
to northern institutions working on DSN-related issues in Asia. 
Purpose and Objectives of the Africa Region DSN Evaluation 
The purposes of the evaluation are learning and accountability: 
[1] Learning from the experience of DSN investments in Africa to inform the work and 
strategy of the Foundation, its grantees and the broader field of disease surveillance. More
specifically, the Evaluation will inform future directions and strategies for current areas of
Foundation Initiative work, particularly in Africa, as well as highlight potential new areas
of work and strategy; and
[2] Accountability to the Board of Trustees, staff and Foundation stakeholders for the DSN
funds invested in the DSN Initiative in Africa.
The main objectives of the evaluation are:
[1] To assess the relevance, effectiveness, efficiency, influence and sustainability of the Rockefeller
Foundation’s support to the work of the Disease Surveillance Networks Initiative in Africa. 
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[2] To assess the underlying hypothesis of the Initiative that robust trans-boundary, multi-sec-
tor and cross-disciplinary collaborative networks lead to improved prediction and detec-
tion disease surveillance and response. Specifically, improved surveillance and response will
include assessment of accuracy of information (in person, place, time) as documented by
surveillance assessments, or outbreak investigations during the term of the Initiative. The
evaluation will not undertake formal disease surveillance system evaluation, but will
exploit secondary data sources for such assessment.
[3] Make forward looking recommendations to the Lead Evaluator and to the Foundation on:
a. The implications of the achievements, challenges and lessons from the DSN Initiative
in Africa for the strategy and work of the Rockefeller Foundation in Africa. This could
include lessons for specific fields of work (health, urban, climate, etc.) as well as lessons
for Initiatives and grantees that aspire to build and sustain networks, build capacity,
and influence policy in Africa; 
b. Priority linkages and synergies for DSN learning to benefit the RF Regional Office for
Africa, the work of other RF Initiatives in Africa, and key RF partners in Africa.
c. Key priorities for funding and partnerships to sustain the gains made by the Founda-
tion in the field of disease surveillance networks in Africa. 
d. Other implications as identified. 
The evaluation also aims to contribute to the field of philanthropy by demonstrating the use of
evaluations in grantmaking, learning and knowledge management, and by informing the field
of development evaluation and assessment about methods for assessing complex networks. 
Components of the Evaluation 
The Africa DSN Evaluation is one component of the overall Global External Evaluation of the
DSN Initiative. The components are: 
[1] A summative and prospective evaluation of DSN Initiative work in the Mekong Region
(being conducted by SEAMEO-TropMed from October 2009 through July 2010).
[2] A summative and prospective evaluation of DSN Initiative work in East and Southern
Africa to be conducted from June through December 2010 (the subject of this TOR—
grantee to be identified). 
[3] A summative and prospective global level strategic evaluation of the influence of the DSN
Initiative globally with key policy partners, funders, practice leaders, and Rockefeller
Foundation-New York (being conducted by the University of Washington, School of Pub-
lic Health from August 2009 through December 2011). 
The Africa and Asia DSN External Evaluations will be both stand-alone products but will also
contribute to the overall global findings of the Global Evaluation. The Lead Global Evaluation
grantee is expected to synthesize the results of the Asia, Africa and Global Evaluation compo-
nents into a final Evaluation Synthesis Report to be delivered to the Foundation in early 2012. 
Annex A: Terms of Reference
Disease 
Surveillance
Networks
Initiative
56
Audiences for the Evaluation 
The Global DSN External Evaluation is commissioned by the President and Executive Manage-
ment Team of the Rockefeller Foundation and managed by the Foundation’s Evaluation Office.
The Africa and Asia components of the Evaluation are commissioned by the Evaluation Office
of the Foundation, and managed by the Global Evaluation grantee in close cooperation with
the Evaluation Office. The RF regional offices for Asia (Bangkok) and Africa (Nairobi) play a
supportive role in assisting with the implementation of the regional evaluations as needed.
The primary audiences for all components of the evaluation are the President, the Board of
Trustees of the Foundation, the Executive Management Team of the Foundation, and the
global and regional Managers of the DSN Initiative. Secondary audiences are the DSN
grantees, partners and other funders in the field of disease surveillance. 
Scope of the Evaluation
The evaluation includes:
u All DSN grantmaking activity of the Rockefeller Foundation to institutions in East and
Southern Africa, as well as grants made to institutions outside of Africa for work aimed at
achieving or advancing the broad objectives of the DSN Initiative in Africa, including
grants pertaining to “One Health”, Health Diplomacy, and disease surveillance enhance-
ment. (See Annex 1 to the RFP for the list of grants).
u The work of the DSN Team and Regional Office in leading and building relationships in
the field of disease surveillance, promoting the One Health Approach, convening Bellagio
forums, and other non-grant work.
Context for the Evaluation 
The emergence of infectious diseases such as HIV/AIDS, Ebola, SARS, highly pathogenic
avian influenza and swine flu is driven by several factors. Increased viral adaptation, popula-
tion density, cross-border mobility and connectivity within the ecosystem, close proximity
with animals, changing animal consumption and production patterns, and ecological shifts
because of climate change allow the rapid spread of disease among and between animals and
humans, creating particular risks for the health and livelihoods of poor people and raising con-
cerns about national security, safety of the food chain, and overall global public health. 
Early detection and containment by effective disease surveillance networks is critical to arrest-
ing pandemics in their early stages. Disease surveillance in most developing countries today is
highly inadequate, with there being great variation in the quality of the disease surveillance
systems. Surveillance systems in most developing countries may be deficient due to lack of
Annex A: Terms of Reference
Final 
Evaluation:
Africa
57
resources, training, policies, or inadequate data collection methodologies. This prevents effec-
tive responses to outbreaks and pandemics and undermines efforts to build resilience to threats
to the health and livelihoods of poor or vulnerable people. 
In Africa, where networks have uniformly embraced the One Health principle—integrating
human, veterinary, and wildlife health officials and scientists—the Rockefeller Foundation is
focusing on translating promising approaches from the Mekong region of Asia to existing and
nascent networks in East and Southern Africa. Methodologies and approaches tested in the
Mekong region are now being applied in East and Southern Africa. For example, the East
African Community, with technical input from the RAND Corporation, conducted the region’s
first pandemic preparedness simulation planning, which is helping to build capacity at regional
and cross-border levels to make strategic plans operational. 
The Southern Africa Centre for Infectious Disease Surveillance (SACIDS)—an organization
that grew out of the U.K. Foresight project and a Rockefeller Foundation-supported meeting
in 2007 at its Bellagio Center, to cover countries in the Southern Africa Development Com-
munity (SADC)—is working with partners in Southeast Asia and the London School of
Hygiene and Tropical Medicine to apply resource mapping efforts to optimize efficiencies in
surveillance. The new network is a strong advocate for One Africa, One Health and improved
surveillance capacity, and the Rockefeller Foundation’s support has catalyzed funding from
Google.org and the Wellcome Trust. 
Each individual grantee in East and Southern Africa has already established connections with
their Mekong-based counterparts. Collectively, they make up CHORDS (Connecting Health
Organizations for Regional Disease Surveillance), which also includes other regional surveil-
lance networks. CHORDS was launched with Rockefeller Foundation support by the Global
Health and Security Initiative (GHSI) at the Nuclear Threat Initiative meeting in Washington,
D.C. in April 2009. 
Performance Areas and Key Evaluation Questions 
The main performance areas and key evaluation questions to be covered in the Africa Evalua-
tion are as follows, and will be further developed in an Evaluation Matrix to be developed and
refined during the planning phase of the Evaluation. The Matrix will be aligned with the
global Evaluation Matrix and to that of the Asia DSN Evaluation. 
[1] Relevance—includes rationale, niche, leadership role, comparative advantage and value
added of the Initiative in East and Southern Africa. 
a. The extent to which the Initiative is relevant to: 
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u state of the art/leading-edge thinking and trends in disease surveillance and response
in Africa. 
u the areas of work of the Foundation in Africa and globally.
u the Stakeholders of the region.
b. The extent to which the Rockefeller Foundation Initiative occupies a niche and plays a
leadership role in the field of health in East and Southern Africa. 
c. The value added of the Initiative to regional collaboration in disease surveillance in
Africa, and to the work of other Foundation Initiatives in Africa. 
d. The comparative advantage of the Foundation in the field of disease surveillance in Africa. 
[2] Effectiveness—includes an assessment of the results of the Initiative in East and 
Southern Africa. This includes an analysis of the products and services planned and pro-
vided, the changes or outcomes that have occurred, as well as the impact the Initiative has
had on people and systems in the region. More specifically the evaluation will explore: 
a. The quality and quantity of planned products and/or outputs associated with the grants
provided by the Foundation in East and Southern Africa. 
b. The extent to which the outputs or products are used by target users in the region.
c. The achievement of objectives and outcomes specifically as they relate to: 
uImproved human resources for disease surveillance in developing countries, thus bol-
stering national capacity to monitor, report and respond to outbreaks; 
uSupport regional networks to promote collaboration in disease surveillance and
response across countries; and 
uBuild bridges between regional and global monitoring efforts.
d. The extent to which early detection and containment of outbreaks with pandemic
potential resulted from the work of the Initiative in the region.
uThe extent to which Africa DSN grantees detect, report and respond to health and
human security threats (primarily disease outbreaks) more broadly and efficiently.
uThe extent to which there is an increase in the number and geographic coverage of
outbreaks reported within the region. 
uChanges in the time to report outbreaks in East and Southern Africa. 
uWhether the responses have been adequate among the DSN partners.
e. The extent to which the Initiative built capacity at the individual, institutional and net-
work levels in the region, including an analysis of the extent to which the strategy of
the Initiative contributed to better detection and management of disease outbreaks in
East and Southern Africa. 
This includes the capacity to detect and control outbreaks through:
uOptimal use of human resources 
u Are resources analyzed and deployed more efficiently to correspond to patterns of out-
breaks and disease spread, and to avert future outbreaks? 
u Are public health staff and communities skilled at adequate levels to detect and report?
uNew communication tools and analytics
u Does information technology support efficient reporting horizontally and vertically? 
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u Were new technologies developed/adapted to meet needs at all levels? 
u Are new technologies more widely accessible?
uNew collaborative approaches to emerging priorities
u Have new models of trans-national and trans-disciplinary collaboration, new 
competencies, and new ways of working emerged or evolved?
uRegional surveillance networks 
u Were sub-national and national human resource and adaptive capacity strengthened? 
u Were new normative practices and expectations established to comply with the 
International Health Regulations in reporting diseases of international concern and 
collaborating in the response?
u How have lessons learned been applied or translated to other regions (across MBDS,
EAIDSNET, SACIDS, others)?
u To what extent have new bodies such as CHORDS been effective in bolstering efficacies
in outbreak responses?
u The sustainability of new networks and the lessons for increased efficacy of these 
networks? 
uRegional and Global collaboration
u Leveraging other donors—How has DSN helped to reduce fragmentation among donors
in East and Southern Africa and globally? 
u What additional resources have contributed to common goals in Africa?
u Health diplomacy—How have DSN processes contributed to building trust and 
collaboration across boundaries?
uOne Health Leadership 
u Has the capacity of leaders to champion the One Health concept and to change practice
and policy in Africa increased, and if so, in what ways?
f. The degree of policy influence that the Initiative has had on policies, public discourse,
and practices in the fields of public health, disease prevention and development in
Africa, and specifically East and Southern Africa. The specific issues to be addressed are:
uTo what extent has the Initiative created policy frameworks that have reduced 
fragmentation of the Africa region? 
uTo what extent are there new specific plans as a result of the Initiative’s work to 
influence policy in the countries of East and Southern Africa? 
uAre there examples that demonstrate how the policies influenced by the Initiative
affected practice in countries in East and Southern Africa?
uTo what extent has the Initiative expanded the policy capacity and broadened policy
horizons of network participants in East and Southern Africa?
uTo what extent has the Initiative influenced policy at the institutional level in Africa? 
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[3] Efficiency—is an assessment of the use of resources to obtain results. To what extent is
the Rockefeller Foundation using best management and governance practices, and are
those practices providing good value for money? The specific issues to be addressed are:
a. To what extent was the Africa component of the DSN Initiative effectively and 
efficiently planned both strategically and operationally? 
b. To what extent did the Initiative provide effective management and leadership of the
Initiative in Africa internally and externally with grantees and partner organizations
(vision, management, leadership, mentoring, etc.)?
c. To what extent was the DSN Africa grant portfolio efficiently managed in order to
deliver the work of the Initiative – picking the right grantees, assessing capacity, 
developing and supporting the delivery of results?
d. Were the resources of the Initiative in Africa adequate for the goals, and used in the
most cost effective manner to achieve the intended outcomes?
e. Did managers adequately search for the most effective and efficient delivery mechanisms
in Africa? 
f. Were sound M&E practices used in Africa?
g. Were learning systems planned and implemented to ensure useful public goods in Africa?
h. Were these public goods shared broadly across other RF Initiatives and within the dis-
ease surveillance community? 
[4] Impact—refers to an assessment of the impact that the Initiative has had on people and
systems in East and Southern Africa. Ideally (provided there is monitoring and baseline
data) this will include an assessment of the extent to which DSN has contributed to (or
directly affected) improvements in the lives of poor and vulnerable people within the
broader population served by the work of African grantees. In addition, if data is available,
this will also include an assessment of the impact on the systems within which poor and
vulnerable people depend (environmental, social, economic, cultural, political, etc). 
[5] Sustainability—refers to the extent to which the Initiative can develop both financial
and/or institutional supports to continue the work started by the Initiative in East and
Southern Africa. Specifically, the extent to which:
a. The efforts (outputs and outcomes) of the Initiative are embedded in ongoing practices
of people, institutions and communities in the region. 
b. The strategies adopted by the Initiative, including an exit strategy, create a high proba-
bility of the main outcomes of the Initiative continuing beyond Rockefeller Foundation
funding in East and Southern Africa.
c. Expanded partnerships exist for scaling up the work in Africa and sustaining the Initia-
tive beyond the Rockefeller Foundation’s support.
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Methodology
The methodology for the Africa DSN Evaluation will mirror and be aligned with the method-
ology for the Global Evaluation and the DSN Asia Evaluation so that these components com-
plement each other and enable the results to be synthesized. 
As with the Global and Asia Evaluations, mixed methods will be used to conduct the evalua-
tion, including grant portfolio reviews, interviews, field visits, surveys, desk studies, case stud-
ies, and focus groups. 
u An analytical review of the Portfolio of the grants funded under the DSN Initiative in
Africa, as well as to grantees outside of Africa, but whose work pertains to DSN activities in
Africa and globally. (The sampling strategy for this will be determined in the planning
phase of the Evaluation.) 
u Field visits to a purposeful sample of the DSN funded work of grantees in East and South-
ern Africa. The field visits will enable the evaluation team to observe work practices in the
sites, utilization of tools, gather pertinent documents for the desk study/literature review
and for the conduct of interviews of partners/grantees and focus group discussions with dif-
ferent groups of stakeholders.
u Stakeholder interviews with:
u disease surveillance leaders, policy makers and practitioners in East and Southern Africa 
u partner organizations and other funders in Africa 
u RF managers in Africa and in New York—both from the DSN Initiative as well as related
Initiatives. 
u Desk study of relevant documents including: 
u Country level documents- country health/animal strategic plans, policy statements, training
documents, health indicators, archived disease surveillance assessments, disease outbreak
reports, HRD plans, scientific papers;
u Regional level – SACIDS, EAIDSNET, etc. work plans and reports, meeting proceedings,
mapping exercises, table top exercises; Other regional organization documents relevant to dis-
ease surveillance and key questions of the evaluation such as IDSR AFRO/CDC regional net-
work, AFRO policy statements, African Union policy statements etc.;
u RF grant documents- grant proposals/plans, progress reports, summative/final reports, grant
letters, relevant regional trip reports, workplans, conference reports, financial reporting, budg-
ets, monitoring reports, etc.; and
u Journal articles/scientific papers relevant to DSN in Africa.
u Focus Groups with participants of training courses, users of tools, implementers of activi-
ties relevant to key evaluation questions in the different sites. The exact number of inter-
views and focus groups to be conducted per site will be determined during the planning
phase of the evaluation.
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u Case Study(s) to illustrate specific aspects of DSN learning in Africa that is of particular
interest or significance to RF and the field of disease surveillance. 
u Other methods to be determined. 
The sampling strategy for in-depth review of grants, desk review, focus groups and field visits
will be determined in the planning phase of the evaluations with the Lead Evaluator. However,
in general, sampling will be purposeful, focusing on a selection of grants that explicitly state
that they expect to contribute to the objectives and outcomes of the Initiative. 
In addition to primary data collected from the portfolio review, interviews, questionnaires and
focus groups, data from other sources such as country health indices (e.g. country specific
mortality rates), archived disease surveillance assessment and disease outbreak reports, and
monitoring and evaluation of related programmatic elements will be identified and brought
into this evaluation effort as appropriate to address the key evaluation questions.
The Evaluation Matrix to be developed in the planning phase by RF and the Lead Evaluator
with the Africa grantee, will identify the data sources to be used to address the specific evalua-
tion questions. 
Evaluation Team 
The Africa Grantee will be responsible for assembling and managing an evaluation team with
extensive experience in the areas of: 
u Evaluation in countries of DSN work in East Africa including (Kenya, Uganda, 
Rwanda, Burundi, Tanzania, DRC, Ethiopia) and Southern Africa (South Africa, Zambia, 
Mozambique, Botswana)
u The use of qualitative and quantitative methods, survey techniques, inventory, observation
and desk review
u Complex program evaluation in Africa
u Network evaluation in Africa
u Disease Surveillance knowledge and experience in Africa 
u Evaluation of One Health approach in Africa
u Evaluation of health policy, health diplomacy in Africa
u Knowledge of, and evaluation experience in, development globally and in Africa
u Management of complex evaluations
u Communication, interviewing and facilitation skills 
u Technical discipline backgrounds for team members should include, but not be limited to:
u Program Evaluation 
u Epidemiology and public health
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u International development and public policy
u Social sciences
u Biostatistics
u Veterinary public health
u Information technology
u Other areas as identified.
u Ability to conduct evaluations in English and write reports in English.
In general the team will have extensive experience in conducting large program evaluations in
Africa, and in the operational aspects of disease surveillance in the East and Southern Africa
region. The majority of evaluation team members will be based in Africa. The Team Leader of
the Evaluation will have extensive experience in managing large program evaluations in Africa. 
Please see the Request for Proposals for further details of expected qualifications. 
Management of the Evaluation 
The Grantee selected to conduct the Africa DSN Evaluation will be responsible for the man-
agement of the evaluation and will be accountable for the timely delivery of high quality eval-
uation products within budget to the Rockefeller Foundation, and to the Lead Evaluation
Grantee, the University of Washington. 
The Team Leader for the Africa DSN Evaluation will be responsible for managing and con-
ducting the Evaluation in coordination with the Lead Evaluation grantee who holds the
responsibility for the synthesis of all three evaluation components (Global, Asia and Africa
evaluations). The Africa DSN Evaluation Grantee will be responsible for maintaining close
coordination and communication with the Lead Evaluator, the Foundation’s Evaluation
Office, the DSN Team and the Africa Office. 
The attached Scope of Work and TOR for the Global Evaluation sets out in detail the roles of the
Lead Evaluator, the Regional Grantees, the RF Evaluation Office and the RF Regional Offices. 
Milestones and Deliverables
Based on the Scope of Work in this document, the Africa DSN Evaluation Grantee is required to:
[1] Manage the Africa evaluation of the Rockefeller Foundation’s support to the Disease 
Surveillance Networks (DSN) during the period, June 1, 2010–December 30, 2010, as
described in this document.
[2] Conduct a summative and prospective evaluation focused on the Performance Areas and
questions outlined in this document. 
[3] Make recommendations to the Foundation on: 
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a. the implications of the achievements, challenges and lessons from the DSN Initiative for
the strategy and investments of the Rockefeller Foundation at a global and region level; 
b. priority linkages and synergies for DSN learning to benefit the work of other Initia-
tives, regional offices, and key partners; and 
c. key priorities for funding and partnerships to sustain the gains made by the Foundation
in the field of disease surveillance networks. 
Timeframe
The Africa DSN Evaluation will be designed during June 2010 and the evaluation conducted
from July through December 2010. An indicative schedule for the evaluation is as follows. This
will be refined during the grantee selection process and in consultation with the RF Africa Office
and DSN Team.
Date Deliverables and Milestones
April 2010
u RFP process for Africa Evaluation grantee
u Evaluation Proposal , CVs of Evaluation Team
May 2010 u Grant awarded
June 2010
Design Phase
u Detailed Evaluation Matrix, Workplan and Methodology (data collection 
strategy, interview protocols, criteria for Portfolio Review, criteria for selection
of grantee field sites)
u Data collection instruments
u Detailed budget and level of effort for team members
July-August 2010
u Portfolio Review
u Data collection, analysis, write-up 
August –October
2010 
u Field Visits, possible case study
October 2010 u Data Analysis
Mid November
2010 
u Draft Report to Lead Evaluator and RF Evaluation Office
End November
2010 
u Presentation—Preliminary Findings to Lead Evaluator and RF Evaluation Officer
Mid December
2010 
u Final Report, including an Executive Summary and Power Point summary of the
key findings and messages suitable for presentation to the management team
of the Foundation and the Board of Trustees. 
Within 2 months
after December 31,
2010 
u Final narrative and financial reports submitted to the Rockefeller Foundation 
(if not submitted earlier), as per the terms of the Grant Agreement. 
www.rockefellerfoundation.org Au
g
u
st
 2
01
1.
 C
o
ve
r 
p
h
o
to
 b
y 
Jo
n
as
 B
en
d
ik
se
n
; 
C
o
u
rt
es
y 
o
f 
th
e 
R
o
ck
ef
el
le
r 
Fo
u
n
d
at
io
n
.
Prof. Jakob Zinsstag
Human and Animal Health Unit
Dept. of Epidemiology and Public Health Unit
Socinstrasse 57
P.O. Box
CH-4002 Basel, Switzerland
T: +41 61 284 81 39
F: +41 61 284 81 05 
E-mail: jakob.zinsstag@unibas.ch 
Website: www.swisstph.ch, www.swisstph.ch/en/research/
public-health-and-epidemiology/human-and-animal-health.html
Dr. Remare Ettarh
African Population and Health Research Center (APHRC)
Shelter Afrique Center, Longonot Road
Upper Hill, PO Box
Nairobi, Kenya
T: +254 20 272 04 00
F: + 254 20 272 03 80
E-mail: rettarh@aphrc.org
Website: www.aphrc.org
